RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Reperfusion Injury |
|
Accession: | DOID:9004009
|
browse the term
|
Definition: | Adverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the tissue (REPERFUSION), including swelling; HEMORRHAGE; NECROSIS; and damage from FREE RADICALS. The most common instance is MYOCARDIAL REPERFUSION INJURY. |
Synonyms: | exact_synonym: | Ischemia Reperfusion Injury; Ischemia-Reperfusion Injuries; Reperfusion Damage; Reperfusion Damages; Reperfusion Injuries |
| primary_id: | MESH:D015427 |
| xref: | EFO:0002687 |
|
|
GViewer not supported for the selected species.
|
|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22749977 |
|
NCBI chrNW_004936763:1,225,355...1,308,257
Ensembl chrNW_004936763:1,226,482...1,297,427
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
|
ISO |
mRNA, protein:increased expression:brain, neuron |
RGD |
PMID:16997484 |
RGD:2301088 |
NCBI chrNW_004936578:5,838,044...5,916,287
Ensembl chrNW_004936578:5,837,993...5,916,274
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
ISO |
mRNA:increased expression:hippocampal granule cell |
RGD |
PMID:19647005 |
RGD:2315956 |
NCBI chrNW_004936672:3,461,387...3,468,053
Ensembl chrNW_004936672:3,460,383...3,468,255
|
|
G |
Adcyap1r1 |
ADCYAP receptor type I |
|
ISO |
mRNA:decreased expression:dentate gyrus (rat) |
RGD |
PMID:19647005 |
RGD:2315956 |
NCBI chrNW_004936478:7,278,081...7,322,970
Ensembl chrNW_004936478:7,278,147...7,318,458
|
|
G |
Adgrl1 |
adhesion G protein-coupled receptor L1 |
|
ISO |
|
RGD |
PMID:12225880 |
RGD:2314400 |
NCBI chrNW_004936659:2,794,520...2,822,795
Ensembl chrNW_004936659:2,794,520...2,822,848
|
|
G |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
|
ISO |
|
RGD |
PMID:12225880 |
RGD:2314400 |
NCBI chrNW_004936582:5,313,215...6,091,351
Ensembl chrNW_004936582:5,338,982...5,819,018
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
associated with Non-alcoholic Fatty Liver Disease; |
RGD |
PMID:18098300 |
RGD:5686804 |
NCBI chrNW_004936578:3,168,599...3,179,369
Ensembl chrNW_004936578:3,168,331...3,171,928
|
|
G |
Adm |
adrenomedullin |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:17263982 |
RGD:7364988 |
NCBI chrNW_004936528:8,005,223...8,007,586
Ensembl chrNW_004936528:8,005,189...8,007,643
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:17937935 PMID:27757725 |
RGD:4890367 |
NCBI chrNW_004936619:597,970...618,564
Ensembl chrNW_004936619:608,441...616,779
|
|
G |
Adora2b |
adenosine A2b receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27757725 |
|
NCBI chrNW_004936821:583,463...608,189
Ensembl chrNW_004936821:580,675...608,245
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
|
ISO |
|
RGD |
PMID:20451506 |
RGD:5129116 |
NCBI chrNW_004936486:4,400,467...4,401,588
Ensembl chrNW_004936486:4,399,915...4,403,149
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
|
RGD |
PMID:14630341 PMID:18336819 |
RGD:1598754 RGD:4145097 |
NCBI chrNW_004936504:5,985,407...5,987,453
Ensembl chrNW_004936504:5,985,960...5,987,210
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chrNW_004936484:19,713,299...19,721,144
Ensembl chrNW_004936484:19,716,165...19,721,261
|
|
G |
Agtr2 |
angiotensin II receptor type 2 |
|
ISO |
|
RGD |
PMID:22920387 |
RGD:6903870 |
NCBI chrNW_004936479:13,252,678...13,255,570
Ensembl chrNW_004936479:13,252,678...13,255,570
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
ISO |
protein:increased expression:Kupffer cell (rat) |
RGD |
PMID:16500929 |
RGD:2313040 |
NCBI chrNW_004936727:1,907,493...1,909,350
Ensembl chrNW_004936727:1,907,505...1,909,338
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
|
RGD |
PMID:21351045 |
RGD:5509067 |
NCBI chrNW_004936621:620,163...639,115
Ensembl chrNW_004936621:620,074...639,093
|
|
G |
Akt1s1 |
AKT1 substrate 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16397181 |
|
NCBI chrNW_004936664:3,657,170...3,664,375
Ensembl chrNW_004936664:3,657,207...3,664,024
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
|
RGD |
PMID:18635843 |
RGD:5509608 |
NCBI chrNW_004936677:3,232,183...3,241,307
Ensembl chrNW_004936677:3,232,183...3,241,253
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
protein:increased expression:cerebral hemisphere CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:14769366 PMID:15266012 PMID:19816089 |
RGD:1626152 RGD:2317531 |
NCBI chrNW_004936554:7,807,914...7,848,691
Ensembl chrNW_004936554:7,808,355...7,867,931
|
|
G |
Ang |
angiogenin |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:19666176 |
RGD:2325717 |
NCBI chrNW_004936880:39,372...40,070
|
|
G |
Angpt1 |
angiopoietin 1 |
|
ISO |
|
RGD |
PMID:19885826 |
RGD:2316041 |
NCBI chrNW_004936470:37,105,469...37,328,183
Ensembl chrNW_004936470:37,105,466...37,328,190
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
ISO |
|
RGD |
PMID:18205898 |
RGD:2292105 |
NCBI chrNW_004936492:14,818,561...14,902,231
Ensembl chrNW_004936492:14,816,623...14,902,132
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
ISO |
protein:increased expression:placenta |
RGD |
PMID:18373555 |
RGD:2315671 |
NCBI chrNW_004936877:666,545...669,351
Ensembl chrNW_004936877:666,523...669,338
|
|
G |
Aqp4 |
aquaporin 4 |
|
ISO |
protein:increased expression:cerebral cortex mRNA, protein:increased expression:parietal cortex |
RGD |
PMID:19806476 PMID:20924629 PMID:20979759 PMID:21718723 |
RGD:5148016 RGD:5148022 RGD:5148037 RGD:5684013 |
NCBI chrNW_004936550:5,931,201...5,943,999
Ensembl chrNW_004936550:5,931,194...5,941,354
|
|
G |
Asl |
argininosuccinate lyase |
resistance |
ISO |
protein:increased expression:brain, neuron (rat) |
RGD |
PMID:17198704 |
RGD:1599263 |
NCBI chrNW_004936543:7,688,788...7,699,842
Ensembl chrNW_004936543:7,688,741...7,699,851
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
resistance |
ISO |
protein:increased expression:brain, neuron (rat) |
RGD |
PMID:17198704 |
RGD:1599263 |
NCBI chrNW_004936487:17,482,307...17,527,407
Ensembl chrNW_004936487:17,486,826...17,527,435
|
|
G |
Bad |
BCL2 associated agonist of cell death |
|
ISO |
protein:altered localization:brain, mitochondria |
RGD |
PMID:18347331 |
RGD:2292679 |
NCBI chrNW_004936599:4,924,349...4,933,683
Ensembl chrNW_004936599:4,924,789...4,933,368
|
|
G |
Bag1 |
BAG cochaperone 1 |
|
ISO |
|
RGD |
PMID:12215270 |
RGD:2296021 |
NCBI chrNW_004936524:1,793,001...1,804,145
Ensembl chrNW_004936524:1,791,119...1,804,151
|
|
G |
Bag3 |
BAG cochaperone 3 |
|
ISO |
protein:increased expression:hippocampus, astrocyte |
RGD |
PMID:12061864 |
RGD:2325848 |
NCBI chrNW_004936486:8,985,871...9,007,461
Ensembl chrNW_004936486:8,985,761...9,007,502
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:18083315 PMID:18221257 |
RGD:2290557 RGD:2293026 |
NCBI chrNW_004936664:2,968,103...2,973,652
Ensembl chrNW_004936664:2,967,865...2,973,820
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15449323 |
|
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G |
Bdnf |
brain derived neurotrophic factor |
|
ISO |
mRNA:increased expression:retina |
RGD |
PMID:20554625 |
RGD:4891135 |
NCBI chrNW_004936540:5,530,081...5,582,765
Ensembl chrNW_004936540:5,529,942...5,585,014
|
|
G |
Becn1 |
beclin 1 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:22306244 |
RGD:6483054 |
NCBI chrNW_004936490:17,518,100...17,531,126
Ensembl chrNW_004936490:17,517,751...17,531,151
|
|
G |
Bid |
BH3 interacting domain death agonist |
|
ISO |
|
RGD |
PMID:19888517 |
RGD:2317562 |
NCBI chrNW_004936807:708,340...750,127
Ensembl chrNW_004936807:708,276...750,093
|
|
G |
Birc5 |
baculoviral IAP repeat containing 5 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:18053646 PMID:18159002 |
RGD:2293126 RGD:2293127 |
NCBI chrNW_004936594:2,812,165...2,820,618
Ensembl chrNW_004936594:2,812,238...2,820,636
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
|
ISO |
|
RGD |
PMID:11245809 |
RGD:2289024 |
NCBI chrNW_004936534:4,707,658...4,871,865
Ensembl chrNW_004936534:4,709,064...4,871,023
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
|
ISO |
mRNA:increased expression:dentate gyrus, granule cell |
RGD |
PMID:10996456 |
RGD:5129486 |
NCBI chrNW_004936726:1,543,263...1,711,422
Ensembl chrNW_004936726:1,543,245...1,704,541
|
|
G |
Bsg |
basigin (Ok blood group) |
|
ISO |
protein:increased expression:basal ganglia |
RGD |
PMID:16029217 |
RGD:2289063 |
NCBI chrNW_004936588:181,688...189,795
Ensembl chrNW_004936588:181,576...189,287
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:9712737 |
RGD:2289078 |
NCBI chrNW_004936567:1,310,525...1,314,469
Ensembl chrNW_004936567:1,309,658...1,314,515
|
|
G |
C3 |
complement C3 |
|
ISO |
protein:increased expression:intestine |
RGD |
PMID:17981193 |
RGD:5129536 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
C3ar1 |
complement C3a receptor 1 |
|
ISO |
|
RGD |
PMID:15159277 |
RGD:5129702 |
NCBI chrNW_004936892:347,547...355,143
Ensembl chrNW_004936892:347,842...349,296
|
|
G |
C5 |
complement C5 |
|
ISO |
|
RGD |
PMID:15158333 |
RGD:1600597 |
NCBI chrNW_004936487:9,391,774...9,474,168
Ensembl chrNW_004936487:9,391,804...9,474,159
|
|
G |
C5ar1 |
complement C5a receptor 1 |
|
ISO |
|
RGD |
PMID:15158333 PMID:15159277 |
RGD:1600597 RGD:5129702 |
NCBI chrNW_004936664:1,026,216...1,033,438
Ensembl chrNW_004936664:1,032,304...1,033,374
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18490106 PMID:23875703 PMID:29568770 |
RGD:13792595 RGD:2293311 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Casp6 |
caspase 6 |
|
ISO |
protein:increased expression, increased activity:small intestine mucosa |
RGD |
PMID:15010362 |
RGD:2301320 |
NCBI chrNW_004936563:912,502...920,025
Ensembl chrNW_004936563:911,304...919,119
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chrNW_004936726:554,627...596,334
Ensembl chrNW_004936726:554,758...595,922
|
|
G |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:29568770 |
RGD:13792595 |
NCBI chrNW_004936474:3,178,097...3,196,130
|
|
G |
Cast |
calpastatin |
|
ISO |
|
RGD |
PMID:11035539 |
RGD:5509823 |
NCBI chrNW_004936523:6,688,153...6,798,184
Ensembl chrNW_004936523:6,686,519...6,798,321
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:8215636 PMID:16682413 PMID:19196076 PMID:20888583 PMID:23743330 PMID:23875703 More...
|
RGD:5130200 RGD:5130760 |
NCBI chrNW_004936533:3,601,270...3,637,128
Ensembl chrNW_004936533:3,600,955...3,637,422
|
|
G |
Cav1 |
caveolin 1 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:17293479 |
RGD:2289123 |
NCBI chrNW_004936589:2,504,235...2,536,778
Ensembl chrNW_004936589:2,504,224...2,537,170
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:lung, secretion (mouse) protein:increased expression:gut |
RGD |
PMID:15542513 PMID:19558673 |
RGD:2307184 RGD:4891479 |
NCBI chrNW_004936490:253,279...259,947
Ensembl chrNW_004936490:253,034...259,965
|
|
G |
Ccnb1 |
cyclin B1 |
|
ISO |
protein;altered expression:cerebral cortex, hippocampus CA1, neuron |
RGD |
PMID:18278459 |
RGD:2315990 |
NCBI chrNW_004936480:400,287...407,677
Ensembl chrNW_004936480:399,224...407,704
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
|
RGD |
PMID:16718823 |
RGD:2289145 |
Ensembl chrNW_004936599:973,838...983,316
|
|
G |
Ccne1 |
cyclin E1 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:17584601 |
RGD:2289275 |
NCBI chrNW_004936570:5,536,817...5,547,880
Ensembl chrNW_004936570:5,536,672...5,548,008
|
|
G |
Ccng1 |
cyclin G1 |
|
ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:9698156 |
RGD:2316027 |
NCBI chrNW_004936515:614,287...621,213
Ensembl chrNW_004936515:614,290...619,963
|
|
G |
Cd2ap |
CD2 associated protein |
|
ISO |
|
RGD |
PMID:16088078 |
RGD:1581187 |
NCBI chrNW_004936476:12,890,595...12,989,046
Ensembl chrNW_004936476:12,890,468...12,987,843
|
|
G |
Cd36 |
CD36 molecule (CD36 blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936810:791,823...838,303
Ensembl chrNW_004936810:758,182...838,365
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:12388354 |
RGD:5508171 |
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
|
RGD |
PMID:12388354 PMID:20659085 |
RGD:5490531 RGD:5508171 |
NCBI chrNW_004936513:10,607,617...10,620,403
Ensembl chrNW_004936513:10,607,617...10,620,403
|
|
G |
Cd44 |
CD44 molecule (IN blood group) |
|
ISO |
protein:increased expression:testis, macrophage protein:increased expression:kidney |
RGD |
PMID:16786159 PMID:16891795 |
RGD:2289354 RGD:2289369 |
NCBI chrNW_004936533:2,949,026...3,033,166
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
|
ISO |
|
RGD |
PMID:20403613 |
RGD:2326175 |
NCBI chrNW_004936557:5,344,373...5,364,234
|
|
G |
Cd59 |
CD59 molecule (CD59 blood group) |
|
ISO |
|
RGD |
PMID:10530491 |
RGD:1600493 |
NCBI chrNW_004936533:4,242,589...4,263,136
|
|
G |
Cdc42 |
cell division cycle 42 |
|
ISO |
protein:increased activation:hippocampus CA1 |
RGD |
PMID:17161586 |
RGD:2298583 |
NCBI chrNW_004936474:7,556,765...7,598,687
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10451498 PMID:16968891 |
RGD:10043817 |
NCBI chrNW_004936476:22,717,308...22,725,127
Ensembl chrNW_004936476:22,717,260...22,725,182
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
|
ISO |
protein:increased expression:skeletal muscle |
RGD |
PMID:15799773 |
RGD:2293627 |
NCBI chrNW_004936587:4,573,166...4,578,480
Ensembl chrNW_004936587:4,572,728...4,578,461
|
|
G |
Chat |
choline O-acetyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chrNW_004936728:653,654...702,433
Ensembl chrNW_004936728:654,638...700,213
|
|
G |
Cldn4 |
claudin 4 |
|
ISO |
protein:increased expression, altered localization:small intestine epithelium |
RGD |
PMID:17375208 |
RGD:2317600 |
NCBI chrNW_004936543:2,984,797...2,986,563
Ensembl chrNW_004936543:2,984,996...2,985,625
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
|
RGD |
PMID:19372445 |
RGD:2314674 |
NCBI chrNW_004936510:3,779,930...3,806,615
Ensembl chrNW_004936510:3,781,210...3,802,693
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
ISO |
|
RGD |
PMID:17565360 |
RGD:5686869 |
NCBI chrNW_004936471:34,438,676...34,475,005
Ensembl chrNW_004936471:34,438,676...34,475,052
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:19563789 |
RGD:4891956 |
NCBI chrNW_004936475:9,443,851...9,454,715
Ensembl chrNW_004936475:9,443,733...9,455,062
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion associated with Anemia, Sickle Cell;protein:increased expression:lung mRNA:increased expression:liver |
RGD |
PMID:16709871 PMID:18589091 PMID:19433855 |
RGD:2311376 RGD:5135307 RGD:5135441 |
NCBI chrNW_004936676:60,869...63,028
Ensembl chrNW_004936676:60,621...63,106
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
|
ISO |
protein:increased expression:retina |
RGD |
PMID:18709383 |
RGD:2306570 |
NCBI chrNW_004936617:4,224,131...4,239,080
Ensembl chrNW_004936617:4,224,131...4,238,796
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
associated with Anemia, Sickle Cell;protein:increased expression:lung |
RGD |
PMID:19433855 |
RGD:5135307 |
NCBI chrNW_004936676:33,580...40,323
Ensembl chrNW_004936676:32,128...40,329
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:18589091 |
RGD:2311376 |
NCBI chrNW_004936762:66,636...69,694
Ensembl chrNW_004936762:66,636...69,373
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:18790177 |
RGD:4781446 |
NCBI chrNW_004936547:479,261...504,757
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:21664436 |
RGD:5144004 |
NCBI chrNW_004936565:1,917,970...1,919,027
|
|
G |
Dcc |
DCC netrin 1 receptor |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:17574219 |
RGD:2314372 |
NCBI chrNW_004936497:10,122,078...11,169,900
Ensembl chrNW_004936497:10,122,617...11,169,803
|
|
G |
Dsg1 |
desmoglein 1 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:19500802 |
RGD:2316254 |
NCBI chrNW_004936682:1,854,637...1,889,426
Ensembl chrNW_004936682:1,853,594...1,889,488
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17470888 PMID:18722366 |
RGD:4892577 |
NCBI chrNW_004936534:885,489...892,292
Ensembl chrNW_004936534:885,287...891,772
|
|
G |
Edn2 |
endothelin 2 |
|
ISO |
|
RGD |
PMID:1479622 |
RGD:1580920 |
NCBI chrNW_004936474:23,061,219...23,064,525
Ensembl chrNW_004936474:23,060,905...23,064,566
|
|
G |
Ednrb |
endothelin receptor type B |
|
ISO |
|
RGD |
PMID:18722366 |
RGD:4892577 |
NCBI chrNW_004936511:3,446,864...3,478,434
Ensembl chrNW_004936511:3,446,839...3,478,434
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
ISO |
protein:hypophosphorylation:cortex, hippocampus: |
RGD |
PMID:15211596 |
RGD:10401223 |
NCBI chrNW_004936588:2,259,236...2,267,692
Ensembl chrNW_004936588:2,258,309...2,266,609
|
|
G |
Efna5 |
ephrin A5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936531:2,217,467...2,267,265
Ensembl chrNW_004936531:2,217,368...2,300,794
|
|
G |
Efnb2 |
ephrin B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936472:5,138,751...5,181,630
Ensembl chrNW_004936472:5,138,745...5,181,668
|
|
G |
Egf |
epidermal growth factor |
resistance |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16417467 PMID:16526316 |
RGD:6906916 |
NCBI chrNW_004936563:1,058,803...1,181,393
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
Lung Reperfusion Injury; protein:increased expression:lung, nucleus (rat) CTD Direct Evidence: marker/mechanism Lung Reperfusion Injury; protein:increased expression:lung, nucleus (mouse) |
RGD CTD |
PMID:12468449 PMID:16488723 PMID:16551742 PMID:19342415 |
RGD:5131887 RGD:5131903 RGD:5131904 |
NCBI chrNW_004936531:7,625,956...7,629,041
Ensembl chrNW_004936531:7,625,892...7,629,749
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19041636 |
|
NCBI chrNW_004936758:960,305...992,152
Ensembl chrNW_004936758:959,734...992,152
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
ISO |
protein:increased phosphorylation:kidney |
RGD |
PMID:15936177 |
RGD:1581062 |
NCBI chrNW_004936712:413,602...454,443
Ensembl chrNW_004936712:414,446...454,449
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
|
ISO |
protein:increased phosphorylation:kidney |
RGD |
PMID:15936177 |
RGD:1581062 |
NCBI chrNW_004936495:10,746,687...10,769,304
Ensembl chrNW_004936495:10,745,923...10,773,199
|
|
G |
Eno2 |
enolase 2 |
|
ISO |
|
RGD |
PMID:17683050 |
RGD:2293745 |
NCBI chrNW_004936709:904,647...913,445
Ensembl chrNW_004936709:904,031...913,451
|
|
G |
Ep300 |
E1A binding protein p300 |
treatment |
ISO |
retina; protein:altered localization:Hsp70, promoter (rat) |
RGD |
PMID:22143029 |
RGD:5686888 |
NCBI chrNW_004936492:696,982...778,132
Ensembl chrNW_004936492:696,960...778,138
|
|
G |
Epha2 |
EPH receptor A2 |
|
ISO |
|
RGD |
PMID:16735461 |
RGD:1580976 |
NCBI chrNW_004936474:3,648,395...3,673,856
Ensembl chrNW_004936474:3,648,550...3,673,861
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
ISO |
|
RGD |
PMID:19471280 |
RGD:5688359 |
NCBI chrNW_004936675:350,357...392,919
Ensembl chrNW_004936675:350,342...392,551
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
ISO |
|
RGD |
PMID:19440222 |
RGD:2313668 |
NCBI chrNW_004936706:1,854,938...1,867,521
Ensembl chrNW_004936706:1,852,359...1,867,745
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936572:3,728,971...3,795,612
Ensembl chrNW_004936572:3,730,327...3,795,625
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
|
RGD |
PMID:20705928 |
RGD:5147777 |
NCBI chrNW_004936562:2,371,725...2,388,617
Ensembl chrNW_004936562:2,372,044...2,388,650
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
|
RGD |
PMID:29568770 |
RGD:13792595 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
|
ISO |
Rat model using human FGF1 |
RGD |
PMID:16635575 PMID:19497570 |
RGD:5509879 RGD:5509881 |
NCBI chrNW_004936504:11,590,687...11,684,410
Ensembl chrNW_004936504:11,590,637...11,685,194
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936471:11,636,733...11,692,782
Ensembl chrNW_004936471:11,635,876...11,693,821
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
protein:increased expression:brain CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:7922267 PMID:15121240 |
RGD:2293779 |
NCBI chrNW_004936488:4,384,710...4,388,118
Ensembl chrNW_004936488:4,384,705...4,388,122
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:15306117 |
RGD:1642465 |
NCBI chrNW_004936599:3,642,504...3,649,294
Ensembl chrNW_004936599:3,642,504...3,648,417
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:15121240 |
RGD:2293779 |
NCBI chrNW_004936493:4,308,683...4,327,102
Ensembl chrNW_004936493:4,304,395...4,327,179
|
|
G |
Gast |
gastrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10594344 |
|
NCBI chrNW_004936490:16,636,146...16,636,548
Ensembl chrNW_004936490:16,636,146...16,636,548
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16581065 |
|
NCBI chrNW_004936602:3,037,862...3,044,863
Ensembl chrNW_004936602:3,038,549...3,042,506
|
|
G |
Gjb1 |
gap junction protein beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25530438 |
|
NCBI chrNW_004936762:389,655...398,035
Ensembl chrNW_004936762:389,669...395,898
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
|
ISO |
protein:decreased activity:brain |
RGD |
PMID:7808037 |
RGD:6484655 |
NCBI chrNW_004936601:5,415,857...5,435,964
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
|
ISO |
|
RGD |
PMID:11367746 |
RGD:13513922 |
NCBI chrNW_004936529:1,779,582...1,801,251
Ensembl chrNW_004936529:1,779,571...1,801,255
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
|
ISO |
|
RGD |
PMID:11367746 |
RGD:13513922 |
NCBI chrNW_004936704:1,031,476...1,075,662
Ensembl chrNW_004936704:1,032,708...1,074,384
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8215636 |
|
NCBI chrNW_004936470:7,765,810...7,770,837
Ensembl chrNW_004936470:7,765,703...7,768,465
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23743330 |
|
NCBI chrNW_004936529:997,943...999,123
Ensembl chrNW_004936529:998,150...998,987
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
|
ISO |
mRNA:decreased expression:hippocampus (rat) |
RGD |
PMID:20408958 |
RGD:4107069 |
NCBI chrNW_004936515:8,937,391...9,236,438
Ensembl chrNW_004936515:8,940,009...9,083,151
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
|
ISO |
|
RGD |
PMID:17639597 |
RGD:2316528 |
NCBI chrNW_004936651:2,756,559...3,401,806
Ensembl chrNW_004936651:2,762,380...3,401,808
|
|
G |
Grik5 |
glutamate ionotropic receptor kainate type subunit 5 |
|
ISO |
|
RGD |
PMID:17639597 |
RGD:2316528 |
NCBI chrNW_004936706:410,806...469,000
Ensembl chrNW_004936706:410,938...464,714
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat) |
RGD |
PMID:20350575 |
RGD:2325867 |
NCBI chrNW_004936530:8,286,101...8,612,183
Ensembl chrNW_004936530:8,287,574...8,608,343
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat) |
RGD |
PMID:20350575 |
RGD:2325867 |
NCBI chrNW_004936587:3,406,055...3,806,956
Ensembl chrNW_004936587:3,405,698...3,804,664
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:24904723 |
RGD:10401882 |
NCBI chrNW_004936792:531,076...579,083
Ensembl chrNW_004936792:531,756...579,166
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
|
RGD |
PMID:17142801 |
RGD:6903953 |
NCBI chrNW_004936599:2,197,681...2,200,642
Ensembl chrNW_004936599:2,197,634...2,201,050
|
|
G |
Hbegf |
heparin binding EGF like growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7635938 |
|
NCBI chrNW_004936531:9,332,939...9,345,039
Ensembl chrNW_004936531:9,332,898...9,345,067
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936734:354,798...428,356
Ensembl chrNW_004936734:356,115...428,779
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
ISO |
Limb Reperfusion Injury Spinal Cord Reperfusion Injury |
RGD |
PMID:16465055 PMID:23816242 |
RGD:9068924 RGD:9068927 |
NCBI chrNW_004936495:5,770,988...5,816,157
Ensembl chrNW_004936495:5,770,669...5,816,157
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO |
|
RGD |
PMID:22392147 |
RGD:10402071 |
NCBI chrNW_004936472:25,236,728...25,246,585
Ensembl chrNW_004936472:25,236,728...25,246,580
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:16009498 PMID:18398369 PMID:21724106 |
RGD:2315888 RGD:5508445 RGD:5508473 |
NCBI chrNW_004936549:1,378,536...1,400,501
Ensembl chrNW_004936549:1,378,736...1,400,532
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
protein:increased expression:serum, Bronchoalveolar Lavage Fluid CTD Direct Evidence: marker/mechanism|therapeutic |
RGD CTD |
PMID:12352873 PMID:12919086 PMID:16699460 PMID:16982915 PMID:17660127 PMID:17906103 PMID:19885035 PMID:23075401 PMID:25780291 More...
|
RGD:1582708 RGD:4145338 RGD:4145514 |
NCBI chrNW_004936492:5,042,353...5,049,216
Ensembl chrNW_004936492:5,042,330...5,049,311
|
|
G |
Hrh3 |
histamine receptor H3 |
|
ISO |
|
RGD |
PMID:17169356 |
RGD:1626416 |
NCBI chrNW_004936514:9,862,104...9,865,614
Ensembl chrNW_004936514:9,862,523...9,873,159
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
associated with Diabetes Mellitus, experimental (D003921): protein:increased expression:brain |
RGD |
PMID:22075494 |
RGD:5685650 |
NCBI chrNW_004936487:13,348,465...13,352,717
Ensembl chrNW_004936487:13,348,465...13,352,717
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10216529 |
|
NCBI chrNW_004936542:7,577,192...7,581,598
Ensembl chrNW_004936542:7,577,149...7,581,923
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19193722 |
|
NCBI chrNW_004936543:2,110,351...2,111,896
Ensembl chrNW_004936543:2,110,304...2,112,186
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11557319 PMID:23743330 |
|
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
|
|
G |
Id3 |
inhibitor of DNA binding 3, HLH protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936474:8,758,098...8,759,684
Ensembl chrNW_004936474:8,758,030...8,759,823
|
|
G |
Ifng |
interferon gamma |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:19514843 |
RGD:2308950 |
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
|
RGD |
PMID:16306169 |
RGD:1598442 |
NCBI chrNW_004936492:11,709,623...11,784,028
Ensembl chrNW_004936492:11,709,222...11,778,351
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12388354 PMID:16141682 PMID:18460982 PMID:19514843 |
RGD:1598625 RGD:2308950 RGD:5508171 |
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il12a |
interleukin 12A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936519:6,166,060...6,180,652
Ensembl chrNW_004936519:6,175,261...6,180,396
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:18354382 |
RGD:2301685 |
NCBI chrNW_004936647:2,529,933...2,532,503
Ensembl chrNW_004936647:2,530,491...2,532,373
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:16052682 PMID:19394645 |
RGD:4889555 RGD:4889825 |
NCBI chrNW_004936612:2,306,963...2,325,086
Ensembl chrNW_004936612:2,306,875...2,325,189
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chrNW_004936783:1,210,715...1,218,315
Ensembl chrNW_004936783:1,210,809...1,218,315
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10594344 PMID:12468449 PMID:15829914 PMID:19058328 PMID:19673871 |
|
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:lung |
CTD RGD |
PMID:15829914 PMID:17032661 PMID:18258783 PMID:19673871 PMID:20659747 PMID:20680426 PMID:21940958 More...
|
RGD:4143250 RGD:4143253 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Il6r |
interleukin 6 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chrNW_004936580:4,055,438...4,081,876
Ensembl chrNW_004936580:4,057,771...4,081,885
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chrNW_004936480:11,867,573...11,913,563
Ensembl chrNW_004936480:11,884,582...11,909,635
|
|
G |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chrNW_004936525:4,046,609...4,154,715
Ensembl chrNW_004936525:4,048,492...4,154,618
|
|
G |
Irak3 |
interleukin 1 receptor associated kinase 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chrNW_004936545:4,233,353...4,284,324
Ensembl chrNW_004936545:4,233,358...4,282,806
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
ISO |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chrNW_004936647:2,686,247...2,693,633
Ensembl chrNW_004936647:2,686,414...2,693,636
|
|
G |
Itga2b |
integrin subunit alpha 2b |
|
ISO |
|
RGD |
PMID:11705748 |
RGD:2316361 |
NCBI chrNW_004936541:813,815...828,826
Ensembl chrNW_004936541:814,171...828,291
|
|
G |
Itga5 |
integrin subunit alpha 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936512:11,588,818...11,612,580
Ensembl chrNW_004936512:11,588,645...11,612,669
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
ISO |
|
RGD |
PMID:11705748 |
RGD:2316361 |
NCBI chrNW_004936541:2,822,789...2,871,069
Ensembl chrNW_004936541:2,815,738...2,871,035
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
|
RGD |
PMID:20440769 |
RGD:6483026 |
NCBI chrNW_004936503:111,722...243,627
Ensembl chrNW_004936503:110,963...241,867
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7922267 |
|
NCBI chrNW_004936522:3,034,364...3,037,632
Ensembl chrNW_004936522:3,035,346...3,036,350
|
|
G |
Kcnj8 |
potassium inwardly rectifying channel subfamily J member 8 |
|
ISO |
|
RGD |
PMID:10708603 |
RGD:1581697 |
NCBI chrNW_004936548:5,125,583...5,132,490
Ensembl chrNW_004936548:5,125,555...5,133,078
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:hippocampus |
CTD RGD |
PMID:16526316 PMID:17402857 |
RGD:5684415 |
NCBI chrNW_004936482:17,537,697...17,581,320
Ensembl chrNW_004936482:17,538,864...17,581,002
|
|
G |
Keap1 |
kelch like ECH associated protein 1 |
|
ISO |
protein:decreased expression:brain, neuron, cytoplasm (mouse) protein:decreased expression:left coronary artery (rat) |
RGD |
PMID:18078953 PMID:21075092 |
RGD:6893270 RGD:6902919 |
NCBI chrNW_004936659:785,059...793,775
Ensembl chrNW_004936659:782,340...793,688
|
|
G |
Klk1 |
kallikrein 1 |
|
ISO |
|
RGD |
PMID:12746231 |
RGD:1641806 |
NCBI chrNW_004936889:534,127...537,913
Ensembl chrNW_004936889:534,161...537,913
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
ISO |
|
RGD |
PMID:17288738 |
RGD:2324630 |
NCBI chrNW_004936659:1,259,405...1,300,545
Ensembl chrNW_004936659:1,259,369...1,302,294
|
|
G |
Lep |
leptin |
|
ISO |
|
RGD |
PMID:21086559 |
RGD:5128549 |
NCBI chrNW_004936479:15,394,966...15,411,334
Ensembl chrNW_004936479:15,394,966...15,411,334
|
|
G |
LOC101954516 |
signal transducer and activator of transcription 5B |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chrNW_004936490:17,022,268...17,043,751
Ensembl chrNW_004936490:17,021,051...17,043,941
|
|
G |
LOC101954950 |
aromatase |
|
ISO |
protein:increased expression:hippocampus (rat) |
RGD |
PMID:21114983 |
RGD:4890041 |
NCBI chrNW_004936471:13,107,603...13,136,910
Ensembl chrNW_004936471:13,107,603...13,136,910
|
|
G |
LOC101955831 |
heat shock 70 kDa protein 1 |
|
ISO |
|
RGD |
PMID:10550516 PMID:10965299 |
RGD:7242748 RGD:7242749 |
NCBI chrNW_004936727:1,718,952...1,721,691
|
|
G |
LOC101956126 |
heat shock 70 kDa protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7922267 |
|
NCBI chrNW_004936727:1,732,323...1,735,128
|
|
G |
LOC101960095 |
antileukoproteinase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8215636 |
|
NCBI chrNW_004936514:7,618,382...7,620,790
Ensembl chrNW_004936514:7,618,261...7,620,912
|
|
G |
LOC101964209 |
C-C chemokine receptor type 1 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:20410256 |
RGD:5688141 |
NCBI chrNW_004936596:177,774...183,186
Ensembl chrNW_004936596:177,812...183,186
|
|
G |
LOC101964975 |
interleukin-8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12865660 |
|
NCBI chrNW_004936598:1,779,471...1,781,353
Ensembl chrNW_004936598:1,779,471...1,781,353
|
|
G |
LOC101966992 |
cytochrome b-245 heavy chain |
|
ISO |
Protein:increase expression:brain CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16766636 PMID:19193722 |
RGD:1599677 |
NCBI chrNW_004936502:4,631,750...4,676,686
Ensembl chrNW_004936502:4,635,149...4,676,904
|
|
G |
LOC101967032 |
cytochrome b-245 light chain |
|
ISO |
|
RGD |
PMID:15148062 |
RGD:1599683 |
NCBI chrNW_004936641:1,036,967...1,044,954
Ensembl chrNW_004936641:1,036,967...1,044,991
|
|
G |
LOC101968920 |
eotaxin |
|
ISO |
mRNA:increased expression:aorta |
RGD |
PMID:9665468 |
RGD:4145482 |
NCBI chrNW_004936538:835,436...848,907
Ensembl chrNW_004936538:835,859...837,710 Ensembl chrNW_004936538:835,859...837,710
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
|
RGD |
PMID:20436217 |
RGD:2325213 |
NCBI chrNW_004936541:4,157,847...4,178,156
Ensembl chrNW_004936541:4,157,393...4,178,177
|
|
G |
LOC101969021 |
somatotropin |
treatment |
ISO |
|
RGD |
PMID:21439711 |
RGD:10003153 |
NCBI chrNW_004936541:4,524,397...4,528,234
|
|
G |
LOC101973029 |
cytochrome P450 2E1 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:21094789 |
RGD:4892235 |
NCBI chrNW_004936486:19,691,822...19,702,684
Ensembl chrNW_004936486:19,691,822...19,702,102
|
|
G |
LOC101973421 |
amine oxidase copper containing 3 |
|
ISO |
|
RGD |
PMID:16339390 |
RGD:2313821 |
NCBI chrNW_004936490:17,549,836...17,564,867
|
|
G |
Manf |
mesencephalic astrocyte derived neurotrophic factor |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:19773801 |
RGD:2325809 |
NCBI chrNW_004936529:2,774,651...2,777,960
Ensembl chrNW_004936529:2,774,543...2,779,579
|
|
G |
Map2 |
microtubule associated protein 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21948028 |
RGD:6483082 |
NCBI chrNW_004936845:475,406...752,600
Ensembl chrNW_004936845:473,366...545,135
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16699462 PMID:20302854 |
RGD:1582310 |
NCBI chrNW_004936728:1,775,746...1,893,895
Ensembl chrNW_004936728:1,775,641...1,893,907
|
|
G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
|
ISO |
protein:increased activity:hippocampus |
RGD |
PMID:16805806 |
RGD:2293339 |
NCBI chrNW_004936694:2,223,020...2,263,388
Ensembl chrNW_004936694:2,222,996...2,263,390
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19667931 PMID:20302854 |
|
NCBI chrNW_004936739:551,678...602,027
Ensembl chrNW_004936739:551,629...602,047
|
|
G |
Mb |
myoglobin |
|
ISO |
|
RGD |
PMID:12788661 |
RGD:1582427 |
NCBI chrNW_004936492:4,890,871...4,897,665
Ensembl chrNW_004936492:4,890,871...4,897,665
|
|
G |
Mc1r |
melanocortin 1 receptor |
no_association |
ISO |
|
RGD |
PMID:18757499 |
RGD:5687323 |
NCBI chrNW_004936641:193,885...198,730
|
|
G |
Mdk |
midkine |
|
ISO |
|
RGD |
PMID:15780085 |
RGD:1582475 |
NCBI chrNW_004936562:2,687,825...2,690,292
Ensembl chrNW_004936562:2,687,825...2,689,484
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:retina (rat) |
RGD |
PMID:17113948 |
RGD:2317505 |
NCBI chrNW_004936589:2,280,803...2,390,179
Ensembl chrNW_004936589:2,280,799...2,390,179
|
|
G |
Mif |
macrophage migration inhibitory factor |
disease_progression |
ISO |
|
RGD |
PMID:18055556 |
RGD:4891010 |
NCBI chrNW_004936619:1,207,058...1,208,010
Ensembl chrNW_004936619:1,203,746...1,208,442
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
associated with lung injury; mRNA, protein:increased expression:lung CTD Direct Evidence: marker/mechanism protein:increased expression:limb muscle (mouse) |
RGD CTD |
PMID:16251419 PMID:16551680 PMID:19545667 PMID:23075401 |
RGD:1582618 RGD:1582631 RGD:5129531 |
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased activity:lung |
CTD RGD |
PMID:8869312 PMID:10706834 PMID:12024109 PMID:16971220 PMID:19058328 PMID:20863214 PMID:21470877 More...
|
RGD:5130958 |
NCBI chrNW_004936490:4,809,773...4,819,070
Ensembl chrNW_004936490:4,809,631...4,819,070
|
|
G |
Mt3 |
metallothionein 3 |
|
ISO |
|
RGD |
PMID:19635467 |
RGD:6480529 |
NCBI chrNW_004936475:8,864,512...8,866,516
Ensembl chrNW_004936475:8,864,675...8,866,506
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
|
RGD |
PMID:23977093 |
RGD:7349380 |
NCBI chrNW_004936580:4,691,870...4,694,092
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25780291 |
|
NCBI chrNW_004936473:27,672,237...27,676,339
Ensembl chrNW_004936473:27,671,797...27,676,372
|
|
G |
Nes |
nestin |
|
ISO |
protein:increased expression:cerebral cortex |
RGD |
PMID:17569338 |
RGD:1642074 |
NCBI chrNW_004936580:5,837,949...5,847,499
Ensembl chrNW_004936580:5,837,936...5,847,020
|
|
G |
Nod2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
protein:increased expression:small intestine |
RGD |
PMID:20107953 |
RGD:5131440 |
NCBI chrNW_004936475:3,708,069...3,742,845
Ensembl chrNW_004936475:3,713,362...3,745,982
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
ISO |
|
RGD |
PMID:17451676 |
RGD:1642142 |
NCBI chrNW_004936558:5,162,471...5,302,488
Ensembl chrNW_004936558:5,233,459...5,301,414
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
mRNA:increased expression:liver mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism protein:increased expression:venule, arteriole, endothelium (mouse) |
RGD CTD |
PMID:10383581 PMID:11592783 PMID:14599979 PMID:19673871 PMID:22019501 PMID:23061969 PMID:23075401 More...
|
RGD:1580938 RGD:2325259 RGD:5509100 |
NCBI chrNW_004936538:4,052,277...4,097,051
Ensembl chrNW_004936538:4,052,448...4,097,051
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21968084 |
|
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
|
|
G |
Nox4 |
NADPH oxidase 4 |
|
ISO |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:18438942 |
RGD:2324666 |
NCBI chrNW_004936736:230,465...394,859
Ensembl chrNW_004936736:230,476...396,708
|
|
G |
Oga |
O-GlcNAcase |
|
ISO |
|
RGD |
PMID:16899550 |
RGD:2305957 |
NCBI chrNW_004936600:3,983,983...3,996,360
|
|
G |
Oprm1 |
opioid receptor mu 1 |
|
ISO |
mRNA, protein:decreased expression:hippocampus |
RGD |
PMID:17360495 |
RGD:2316611 |
NCBI chrNW_004936489:6,506,207...6,567,136
Ensembl chrNW_004936489:6,506,207...6,548,946
|
|
G |
Otc |
ornithine transcarbamylase |
|
ISO |
protein:increased activity:serum |
RGD |
PMID:1499453 |
RGD:4144083 |
NCBI chrNW_004936502:5,234,253...5,291,891
Ensembl chrNW_004936502:5,234,253...5,291,891
|
|
G |
Parp1 |
poly(ADP-ribose) polymerase 1 |
|
ISO |
protein:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:9390645 PMID:15696051 PMID:16798486 PMID:21850691 |
RGD:5510018 RGD:5510020 |
NCBI chrNW_004936526:3,102,468...3,147,601
Ensembl chrNW_004936526:3,102,039...3,147,642
|
|
G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
|
ISO |
|
RGD |
PMID:19142196 |
RGD:6483555 |
NCBI chrNW_004936485:2,611,313...2,866,260
Ensembl chrNW_004936485:2,608,353...2,866,294
|
|
G |
Pde5a |
phosphodiesterase 5A |
|
ISO |
|
RGD |
PMID:19474186 |
RGD:2314462 |
NCBI chrNW_004936869:24,265...117,120
Ensembl chrNW_004936869:39,122...117,127
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
protein:increased expression:brain (mouse) protein:decreased expression:lung (rat) |
RGD |
PMID:12121711 PMID:21872880 PMID:22382321 |
RGD:2311660 RGD:6766379 RGD:6771206 |
NCBI chrNW_004936541:4,873,459...4,919,787
Ensembl chrNW_004936541:4,873,182...4,937,500
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
ISO |
proetin:decreased dimerization:skeletal muscle (rat) |
RGD |
PMID:19100383 |
RGD:4108481 |
NCBI chrNW_004936480:1,188,408...1,273,210
Ensembl chrNW_004936480:1,188,183...1,273,537
|
|
G |
Pink1 |
PTEN induced kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35312153 |
|
NCBI chrNW_004936474:6,574,471...6,589,478
Ensembl chrNW_004936474:6,573,623...6,589,478
|
|
G |
Pklr |
pyruvate kinase L/R |
|
ISO |
|
RGD |
PMID:17013507 |
RGD:1625588 |
NCBI chrNW_004936580:4,770,977...4,799,316
Ensembl chrNW_004936580:4,767,109...4,779,916
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12967936 |
|
NCBI chrNW_004936474:6,091,978...6,095,961
Ensembl chrNW_004936474:6,091,941...6,096,057
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
|
ISO |
protein:increased activity:alveolar macrophage |
RGD |
PMID:1642455 |
RGD:1642456 |
NCBI chrNW_004936481:3,559,377...3,689,797
Ensembl chrNW_004936481:3,559,358...3,689,833
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:9472885 PMID:15223382 |
RGD:2311674 |
NCBI chrNW_004936785:476,200...503,371
Ensembl chrNW_004936785:476,078...503,321
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
protein:increased expression:spinal cord (rat) CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:15181847 PMID:18586014 PMID:19663807 |
RGD:6483808 RGD:6483830 |
NCBI chrNW_004936521:5,238,128...5,243,829
Ensembl chrNW_004936521:5,238,093...5,243,877
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
|
ISO |
|
RGD |
PMID:18606671 |
RGD:6483829 |
NCBI chrNW_004936706:840,968...855,552
|
|
G |
Pld2 |
phospholipase D2 |
|
ISO |
mRNA:decreased expression:brainstem, cerebellum protein:increased expression:hippocampus CA1, hippocampus granule cell layer |
RGD |
PMID:17024567 PMID:17393174 |
RGD:2299901 RGD:2299902 |
NCBI chrNW_004936677:2,870,664...2,883,545
Ensembl chrNW_004936677:2,870,660...2,883,567
|
|
G |
Pnmt |
phenylethanolamine N-methyltransferase |
|
ISO |
protein:increased expression:medulla oblongata (human) |
RGD |
PMID:21061149 |
RGD:5128821 |
NCBI chrNW_004936490:14,858,682...14,861,614
Ensembl chrNW_004936490:14,858,603...14,865,321
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
liver ischemia/reperfusion injury CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:19151258 PMID:21305343 |
RGD:5509942 |
NCBI chrNW_004936629:3,672,445...3,725,645
Ensembl chrNW_004936629:3,672,460...3,725,626
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12468449 PMID:24011919 PMID:24433871 |
|
NCBI chrNW_004936602:1,230,907...1,368,588
Ensembl chrNW_004936602:1,230,907...1,304,743
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
|
ISO |
|
RGD |
PMID:14762344 |
RGD:1580702 |
NCBI chrNW_004936520:1,987,989...2,146,473
Ensembl chrNW_004936520:1,987,045...2,146,540
|
|
G |
Ppp3cb |
protein phosphatase 3 catalytic subunit beta |
|
ISO |
|
RGD |
PMID:14615291 |
RGD:1580705 |
NCBI chrNW_004936521:5,576,705...5,614,738
Ensembl chrNW_004936521:5,575,996...5,615,370
|
|
G |
Prdx6 |
peroxiredoxin 6 |
|
ISO |
|
RGD |
PMID:16766642 |
RGD:1580710 |
NCBI chrNW_004936481:14,223,422...14,233,634
Ensembl chrNW_004936481:14,222,696...14,233,641
|
|
G |
Prkca |
protein kinase C alpha |
|
ISO |
|
RGD |
PMID:17905752 |
RGD:2292474 |
NCBI chrNW_004936541:6,231,604...6,488,201
Ensembl chrNW_004936541:6,233,110...6,488,052
|
|
G |
Ptafr |
platelet activating factor receptor |
treatment |
ISO |
|
RGD |
PMID:11139461 PMID:12812996 |
RGD:10043168 RGD:1581279 |
NCBI chrNW_004936474:12,333,905...12,337,140
Ensembl chrNW_004936474:12,336,071...12,337,099
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:17239858 PMID:19038262 |
RGD:2292538 |
NCBI chrNW_004936735:1,252,414...1,338,318
Ensembl chrNW_004936735:1,252,414...1,338,323
|
|
G |
Ptges |
prostaglandin E synthase |
|
ISO |
|
RGD |
PMID:12431630 PMID:16864802 |
RGD:2300094 RGD:2300116 |
NCBI chrNW_004936487:16,959,263...16,968,909
Ensembl chrNW_004936487:16,959,231...16,968,922
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10594344 PMID:16385084 |
RGD:5688223 |
NCBI chrNW_004936487:10,745,465...10,758,812
Ensembl chrNW_004936487:10,745,327...10,758,823
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:decreased expression:kidney CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10588920 PMID:10594344 PMID:11567657 PMID:16247333 PMID:16386242 PMID:18258783 PMID:19673871 PMID:21394482 PMID:21944479 More...
|
RGD:1580660 RGD:5135045 RGD:5508180 |
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
|
ISO |
protein:increased tyrosine phosphorylation:kidney |
RGD |
PMID:17620366 |
RGD:2292577 |
NCBI chrNW_004936470:10,379,855...10,578,531
Ensembl chrNW_004936470:10,379,872...10,578,543
|
|
G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
ISO |
protein:increased phosphorylation:hippocampus |
RGD |
PMID:15970382 |
RGD:1642621 |
NCBI chrNW_004936675:216,970...325,670
Ensembl chrNW_004936675:275,288...324,810
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:nucleus, liver |
CTD RGD |
PMID:18621400 PMID:20302854 PMID:23743330 |
RGD:2298777 |
NCBI chrNW_004936599:3,800,142...3,810,583
Ensembl chrNW_004936599:3,801,636...3,809,813
|
|
G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
ISO |
|
RGD |
PMID:16403835 |
RGD:1580913 |
NCBI chrNW_004936748:1,244,962...1,250,093
Ensembl chrNW_004936748:1,245,538...1,250,093
|
|
G |
Scfd1 |
sec1 family domain containing 1 |
|
ISO |
protein:increased expression:cerebral cortex |
RGD |
PMID:9195952 |
RGD:633771 |
NCBI chrNW_004936494:5,410,219...5,501,687
Ensembl chrNW_004936494:5,410,269...5,501,498
|
|
G |
Sele |
selectin E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17112405 PMID:19489247 PMID:23743330 |
RGD:2313598 |
NCBI chrNW_004936481:16,915,203...16,921,840
Ensembl chrNW_004936481:16,915,182...16,921,840
|
|
G |
Sell |
selectin L |
|
ISO |
|
RGD |
PMID:19489247 |
RGD:2313598 |
NCBI chrNW_004936481:17,022,421...17,032,105
Ensembl chrNW_004936481:17,022,580...17,032,124
|
|
G |
Selp |
selectin P |
|
ISO |
|
RGD |
PMID:18521901 PMID:21701413 |
RGD:2312314 RGD:6218990 |
NCBI chrNW_004936481:17,076,660...17,112,501
Ensembl chrNW_004936481:17,076,536...17,107,963
|
|
G |
Serpine2 |
serpin family E member 2 |
|
ISO |
|
RGD |
PMID:8261109 |
RGD:2317936 |
NCBI chrNW_004936569:5,642,328...5,668,278
Ensembl chrNW_004936569:5,642,264...5,668,323
|
|
G |
Serping1 |
serpin family G member 1 |
treatment |
ISO |
|
RGD |
PMID:23991040 |
RGD:8661644 |
NCBI chrNW_004936581:4,911,403...4,924,484
Ensembl chrNW_004936581:4,908,458...4,924,645
|
|
G |
Sftpc |
surfactant protein C |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:20560845 |
RGD:4144062 |
NCBI chrNW_004936555:5,966,610...5,982,083
Ensembl chrNW_004936555:5,979,417...5,982,011
|
|
G |
Si |
sucrase-isomaltase |
|
ISO |
|
RGD |
PMID:9724271 |
RGD:1625550 |
NCBI chrNW_004936707:1,153,538...1,228,220
Ensembl chrNW_004936707:1,153,538...1,228,220
|
|
G |
Sirt7 |
sirtuin 7 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28675767 |
|
NCBI chrNW_004936594:5,418,331...5,425,050
Ensembl chrNW_004936594:5,418,796...5,424,988
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
|
ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:19781384 |
RGD:2313601 |
NCBI chrNW_004936474:24,205,878...24,236,611
Ensembl chrNW_004936474:24,206,644...24,236,713
|
|
G |
Slc30a4 |
solute carrier family 30 member 4 |
|
ISO |
mRNA:increased expression:brain |
RGD |
PMID:18289514 |
RGD:2299950 |
NCBI chrNW_004936471:8,125,839...8,155,720
Ensembl chrNW_004936471:8,125,759...8,155,726
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
ISO |
protein:decreased expression:renal proximal tubule |
RGD |
PMID:15775707 |
RGD:2311304 |
NCBI chrNW_004936597:1,667,700...1,684,533
Ensembl chrNW_004936597:1,667,569...1,684,539
|
|
G |
Slc6a11 |
solute carrier family 6 member 11 |
|
ISO |
|
RGD |
PMID:13678673 |
RGD:1299345 |
NCBI chrNW_004936602:2,437,653...2,564,309
Ensembl chrNW_004936602:2,439,813...2,564,313
|
|
G |
Slc8a1 |
solute carrier family 8 member A1 |
|
ISO |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chrNW_004936508:10,894,918...11,256,084
Ensembl chrNW_004936508:10,968,656...11,253,070
|
|
G |
Slc8a2 |
solute carrier family 8 member A2 |
|
ISO |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chrNW_004936664:1,116,543...1,139,586
Ensembl chrNW_004936664:1,116,491...1,139,586
|
|
G |
Slc8a3 |
solute carrier family 8 member A3 |
|
ISO |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chrNW_004936495:13,236,480...13,370,973
Ensembl chrNW_004936495:13,236,470...13,371,011
|
|
G |
Slc9a1 |
solute carrier family 9 member A1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:19027022 PMID:20337040 |
RGD:6771332 |
NCBI chrNW_004936474:11,460,266...11,517,420
Ensembl chrNW_004936474:11,459,929...11,517,478
|
|
G |
Slco1b3 |
solute carrier organic anion transporter family member 1B3 |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:16858290 |
RGD:2303111 |
NCBI chrNW_004936548:5,593,908...5,682,187
|
|
G |
Slk |
STE20 like kinase |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:12965890 |
RGD:2304069 |
NCBI chrNW_004936600:2,134,374...2,193,302
Ensembl chrNW_004936600:2,137,798...2,193,192
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chrNW_004936530:9,312,965...9,315,593
Ensembl chrNW_004936530:9,312,965...9,316,165
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
ISO |
associated with Brain Ischemia;mRNA, protein:increased expression:cerebral cortex |
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chrNW_004936594:2,932,297...2,935,358
Ensembl chrNW_004936594:2,933,747...2,934,451
|
|
G |
Socs4 |
suppressor of cytokine signaling 4 |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chrNW_004936697:110,637...129,767
Ensembl chrNW_004936697:110,952...129,686
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
RGD CTD |
PMID:15364863 PMID:16397181 PMID:23061969 PMID:23743330 |
RGD:1580834 |
NCBI chrNW_004936500:10,345,154...10,352,873
Ensembl chrNW_004936500:10,345,154...10,352,867
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism|therapeutic |
RGD CTD |
PMID:8215636 PMID:15087276 PMID:15612529 PMID:16682413 PMID:19193722 PMID:19917352 PMID:21940958 PMID:23743330 More...
|
RGD:1581259 RGD:1582141 |
NCBI chrNW_004936489:11,178,338...11,191,601
Ensembl chrNW_004936489:11,178,015...11,191,781
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
|
RGD |
PMID:20548025 |
RGD:6903275 |
NCBI chrNW_004936905:148,956...156,023
Ensembl chrNW_004936905:148,945...156,079
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
|
ISO |
protein:increased phosphorylation:hippocampus CA1 (rat) |
RGD |
PMID:20197063 |
RGD:2325012 |
NCBI chrNW_004936561:3,826,802...3,844,406
Ensembl chrNW_004936561:3,825,787...3,844,483
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
ISO |
protein:increased serine phosphorylation:brain protein:increased phosphorylation:kidney |
RGD |
PMID:15262323 PMID:17670769 |
RGD:1600103 RGD:2291900 |
NCBI chrNW_004936506:7,196,860...7,235,854
Ensembl chrNW_004936506:7,196,797...7,233,756
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chrNW_004936646:747,178...763,449
Ensembl chrNW_004936646:748,727...761,287
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chrNW_004936490:17,119,189...17,178,402
Ensembl chrNW_004936490:17,117,290...17,178,402
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chrNW_004936646:1,297,530...1,312,508
Ensembl chrNW_004936646:1,296,290...1,312,157
|
|
G |
Stc1 |
stanniocalcin 1 |
|
ISO |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:15485913 |
RGD:2324700 |
NCBI chrNW_004936555:7,240,649...7,251,668
Ensembl chrNW_004936555:7,239,198...7,251,670
|
|
G |
Stc2 |
stanniocalcin 2 |
|
ISO |
mRNA, protein:increased expression:cerebral cortex |
RGD |
PMID:15485913 |
RGD:2324700 |
NCBI chrNW_004936609:2,319,546...2,331,049
Ensembl chrNW_004936609:2,319,111...2,332,988
|
|
G |
Tbxas1 |
thromboxane A synthase 1 |
|
ISO |
associated with Cholestasis, Extrahepatic |
RGD |
PMID:8680115 PMID:15000260 |
RGD:1601451 RGD:1601475 |
NCBI chrNW_004936592:4,038,163...4,192,772
Ensembl chrNW_004936592:4,038,074...4,192,808
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16968891 |
|
NCBI chrNW_004936815:468,987...492,666
Ensembl chrNW_004936815:469,020...491,697
|
|
G |
Tfam |
transcription factor A, mitochondrial |
|
ISO |
|
RGD |
PMID:22266265 |
RGD:6767573 |
NCBI chrNW_004936614:4,595,973...4,605,040
Ensembl chrNW_004936614:4,596,617...4,605,104
|
|
G |
Tgfbr2 |
transforming growth factor beta receptor 2 |
|
ISO |
|
RGD |
PMID:15613744 |
RGD:1579926 |
NCBI chrNW_004936473:21,324,669...21,409,430
Ensembl chrNW_004936473:21,324,658...21,409,430
|
|
G |
Th |
tyrosine hydroxylase |
|
ISO |
protein:increased expression:medulla oblongata (human) |
RGD |
PMID:21061149 |
RGD:5128821 |
NCBI chrNW_004936794:478,651...486,887
Ensembl chrNW_004936794:478,614...487,061
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
|
RGD |
PMID:19342415 |
RGD:5131887 |
NCBI chrNW_004936620:2,563,900...2,568,117
|
|
G |
Thbs1 |
thrombospondin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936471:3,064,466...3,081,125
Ensembl chrNW_004936471:3,064,422...3,081,949
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chrNW_004936542:4,323,905...4,329,940
Ensembl chrNW_004936542:4,323,408...4,330,077
|
|
G |
Ticam1 |
toll like receptor adaptor molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25780291 |
|
NCBI chrNW_004936588:2,818,909...2,827,797
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
ISO |
protein:decreased expression:brain |
RGD |
PMID:17551674 |
RGD:2290424 |
NCBI chrNW_004936492:6,996,627...7,046,137
Ensembl chrNW_004936492:6,996,613...7,046,190
|
|
G |
Tjp1 |
tight junction protein 1 |
|
ISO |
protein:decreased expression:brain, endothelial cell |
RGD |
PMID:19374856 PMID:19929946 |
RGD:2325127 RGD:2325135 |
NCBI chrNW_004936483:1,814,870...2,045,802
Ensembl chrNW_004936483:1,814,894...2,030,946
|
|
G |
Tlr2 |
toll like receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:kidney |
CTD RGD |
PMID:15912106 PMID:25780291 |
RGD:2312727 |
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
|
|
G |
Tlr3 |
toll like receptor 3 |
|
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:21355876 |
RGD:5128693 |
NCBI chrNW_004936554:3,370,766...3,388,125
Ensembl chrNW_004936554:3,369,469...3,385,907
|
|
G |
Tlr4 |
toll like receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver |
RGD CTD |
PMID:17126102 PMID:19473433 PMID:25780291 PMID:27064547 |
RGD:2312503 RGD:4144169 |
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
|
|
G |
Tmbim6 |
transmembrane BAX inhibitor motif containing 6 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:18005084 |
RGD:2291961 |
NCBI chrNW_004936512:7,427,926...7,448,700
Ensembl chrNW_004936512:7,427,729...7,449,078
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10706834 PMID:12024109 PMID:15829914 PMID:16971220 PMID:17112405 PMID:18460982 PMID:19058328 PMID:23743330 PMID:23875703 PMID:24898700 More...
|
|
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
|
RGD |
PMID:17109621 |
RGD:1624182 |
NCBI chrNW_004936709:1,407,327...1,421,448
Ensembl chrNW_004936709:1,407,278...1,421,921
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
protein:increased expression:brain, mitochondrion |
RGD |
PMID:17661174 |
RGD:2290568 |
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
|
|
G |
Trpc6 |
transient receptor potential cation channel subfamily C member 6 |
treatment |
ISO |
|
RGD |
PMID:20554625 |
RGD:4891135 |
NCBI chrNW_004936551:6,173,588...6,282,971
Ensembl chrNW_004936551:6,174,122...6,282,925
|
|
G |
Trpm7 |
transient receptor potential cation channel subfamily M member 7 |
|
ISO |
mRNA,protein:increased expression:hippocampus |
RGD |
PMID:18395621 |
RGD:5684390 |
NCBI chrNW_004936471:12,564,617...12,666,229
Ensembl chrNW_004936471:12,565,054...12,665,962
|
|
G |
Txn |
thioredoxin |
|
ISO |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chrNW_004936559:2,811,786...2,822,528
Ensembl chrNW_004936559:2,811,782...2,822,528
|
|
G |
Txn2 |
thioredoxin 2 |
|
ISO |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chrNW_004936492:4,310,394...4,320,714
Ensembl chrNW_004936492:4,311,287...4,321,763
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
|
ISO |
mRNA:decreased expression:spinal cord mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 PMID:19409971 |
RGD:5685028 RGD:5685030 |
NCBI chrNW_004936492:10,185,096...10,244,466
Ensembl chrNW_004936492:10,187,206...10,225,989
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
|
ISO |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chrNW_004936619:3,789,940...3,847,286
Ensembl chrNW_004936619:3,791,418...3,847,626
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:18813897 |
RGD:2313108 |
NCBI chrNW_004936748:785,491...802,791
Ensembl chrNW_004936748:785,455...803,048
|
|
G |
Vegfc |
vascular endothelial growth factor C |
|
ISO |
|
RGD |
PMID:18704465 |
RGD:2315487 |
NCBI chrNW_004936516:7,217,543...7,332,531
Ensembl chrNW_004936516:7,217,543...7,332,559
|
|
G |
Vegfd |
vascular endothelial growth factor D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936470:4,761,827...4,794,751
Ensembl chrNW_004936470:4,762,332...4,793,938
|
|
G |
Vim |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chrNW_004936520:10,051,692...10,059,324
Ensembl chrNW_004936520:10,052,012...10,059,182
|
|
G |
Vip |
vasoactive intestinal peptide |
|
ISO |
|
RGD |
PMID:21693218 |
RGD:5685379 |
NCBI chrNW_004936489:5,425,778...5,434,483
Ensembl chrNW_004936489:5,425,726...5,434,785
|
|
G |
Wnt3a |
Wnt family member 3A |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23875703 |
|
NCBI chrNW_004936864:150,742...179,205
Ensembl chrNW_004936864:150,732...192,423
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12910483 PMID:23403765 |
RGD:7247700 |
NCBI chrNW_004936493:1,762,814...1,824,501
Ensembl chrNW_004936493:1,762,869...1,823,238
|
|
G |
Znf354a |
zinc finger protein 354A |
|
ISO |
mRNA:decreased expression:kidney |
RGD |
PMID:8382778 |
RGD:1300202 |
NCBI chrNW_004936647:16,233...18,411
Ensembl chrNW_004936647:15,966...17,935
|
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
|
RGD |
PMID:9916935 |
RGD:11341701 |
NCBI chrNW_004936537:4,637,028...4,647,915
Ensembl chrNW_004936537:4,636,667...4,647,916
|
|
G |
Hnrnpk |
heterogeneous nuclear ribonucleoprotein K |
|
ISO |
|
RGD |
PMID:21489814 |
RGD:155260371 |
NCBI chrNW_004936828:827,660...839,088
Ensembl chrNW_004936828:828,837...838,720
|
|
G |
Pdgfd |
platelet derived growth factor D |
|
ISO |
|
RGD |
PMID:19213942 |
RGD:9854642 |
NCBI chrNW_004936551:3,974,140...4,197,852
Ensembl chrNW_004936551:3,974,104...4,198,927
|
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
treatment |
ISO |
|
RGD |
PMID:22217518 PMID:23769041 |
RGD:7245568 RGD:8695995 |
NCBI chrNW_004936727:1,418,342...1,422,005
Ensembl chrNW_004936727:1,418,799...1,422,147
|
|
G |
C3 |
complement C3 |
treatment |
ISO |
|
RGD |
PMID:25122638 |
RGD:11040803 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:22826618 |
RGD:11352297 |
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
ISO |
liver |
RGD |
PMID:22826618 |
RGD:11352297 |
NCBI chrNW_004936513:10,607,617...10,620,403
Ensembl chrNW_004936513:10,607,617...10,620,403
|
|
G |
F7 |
coagulation factor VII |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:12095034 |
RGD:11049508 |
NCBI chrNW_004936472:505,751...515,375
Ensembl chrNW_004936472:505,751...514,339
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO |
|
RGD |
PMID:22217518 |
RGD:7245568 |
NCBI chrNW_004936472:25,236,728...25,246,585
Ensembl chrNW_004936472:25,236,728...25,246,580
|
|
G |
Kcnn4 |
potassium calcium-activated channel subfamily N member 4 |
ameliorates |
ISO |
|
RGD |
PMID:24312257 |
RGD:401700379 |
NCBI chrNW_004936706:940,585...952,484
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
treatment |
ISO |
|
RGD |
PMID:23985719 |
RGD:10041002 |
NCBI chrNW_004936474:158,376...282,310
Ensembl chrNW_004936474:157,590...282,342
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
|
RGD |
PMID:24598936 |
RGD:10450586 |
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
|
G |
Aco1 |
aconitase 1 |
|
ISO |
|
RGD |
PMID:20176611 |
RGD:11541086 |
NCBI chrNW_004936524:1,081,672...1,134,971
Ensembl chrNW_004936524:1,081,696...1,134,971
|
|
G |
Ccn2 |
cellular communication network factor 2 |
disease_progression |
ISO |
mRNA, protein:increased expression:kidney (rat) |
RGD |
PMID:19921985 |
RGD:150517553 |
NCBI chrNW_004936560:42,561...45,748
Ensembl chrNW_004936560:42,537...45,807
|
|
G |
Clu |
clusterin |
treatment |
ISO |
|
RGD |
PMID:22494435 |
RGD:9068431 |
NCBI chrNW_004936675:499,745...513,515
Ensembl chrNW_004936675:499,199...513,836
|
|
G |
Cs |
citrate synthase |
treatment |
ISO |
|
RGD |
PMID:20005400 |
RGD:243048470 |
NCBI chrNW_004936646:676,926...704,988
Ensembl chrNW_004936646:678,307...692,777
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
treatment |
ISO |
|
RGD |
PMID:18209025 |
RGD:9685339 |
NCBI chrNW_004936551:5,388,456...5,395,071
Ensembl chrNW_004936551:5,388,459...5,395,071
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
|
ISO |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chrNW_004936754:808,894...828,554
Ensembl chrNW_004936754:808,213...828,613
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
mRNA:increased expression:kidney: |
RGD |
PMID:11889420 PMID:15785371 |
RGD:10449491 RGD:11080974 |
NCBI chrNW_004936492:2,353,840...2,368,573
Ensembl chrNW_004936492:2,353,841...2,368,573
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
|
ISO |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chrNW_004936482:16,804,129...16,853,539
Ensembl chrNW_004936482:16,807,569...16,853,587
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
ISO |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chrNW_004936504:4,762,251...4,799,789
Ensembl chrNW_004936504:4,762,184...4,799,829
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
protein:increased secretion:T lymphocyte (human) |
RGD |
PMID:16387096 |
RGD:7241259 |
NCBI chrNW_004936521:5,238,128...5,243,829
Ensembl chrNW_004936521:5,238,093...5,243,877
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
ISO |
protein:increased expression:kidney: |
RGD |
PMID:16221712 |
RGD:13208600 |
NCBI chrNW_004936602:1,230,907...1,368,588
Ensembl chrNW_004936602:1,230,907...1,304,743
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO |
protein:increased expression:kidney: |
RGD |
PMID:16221712 PMID:18192922 |
RGD:13208600 RGD:13208601 |
NCBI chrNW_004936543:1,032,543...1,040,956
Ensembl chrNW_004936543:1,032,794...1,039,123
|
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:22305384 |
RGD:10395369 |
NCBI chrNW_004936508:5,855,748...5,938,879
Ensembl chrNW_004936508:5,855,732...5,938,856
|
|
|
G |
Kit |
KIT proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA,protein:decreased expression:stomach: |
RGD |
PMID:20040059 |
RGD:12911222 |
NCBI chrNW_004936482:17,162,854...17,238,319
Ensembl chrNW_004936482:17,162,950...17,238,274
|
|
G |
Kitlg |
KIT ligand |
|
ISO |
mRNA:decreased expression:stomach: |
RGD |
PMID:20040059 |
RGD:12911222 |
NCBI chrNW_004936507:5,566,144...5,650,412
Ensembl chrNW_004936507:5,565,821...5,650,828
|
|
|
G |
Agt |
angiotensinogen |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:15001561 |
RGD:13515113 |
NCBI chrNW_004936484:19,713,299...19,721,144
Ensembl chrNW_004936484:19,716,165...19,721,261
|
|
G |
Ahr |
aryl hydrocarbon receptor |
treatment |
ISO |
|
RGD |
PMID:22079846 PMID:37387514 |
RGD:401794136 RGD:407419876 |
NCBI chrNW_004936546:3,737,908...3,783,492
Ensembl chrNW_004936546:3,737,851...3,783,588
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
treatment |
ISO |
|
RGD |
PMID:24232000 |
RGD:13792678 |
NCBI chrNW_004936588:612,255...614,894
Ensembl chrNW_004936588:611,725...617,782
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:23946597 |
RGD:13782356 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:23946597 |
RGD:13782356 |
NCBI chrNW_004936474:3,178,097...3,196,130
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
protein:increased expression:heart, kidney, liver, lung |
RGD |
PMID:22493902 |
RGD:9685194 |
NCBI chrNW_004936531:9,572,392...9,575,771
Ensembl chrNW_004936531:9,571,796...9,575,923
|
|
G |
Cldn1 |
claudin 1 |
|
ISO |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chrNW_004936578:98,489...113,125
Ensembl chrNW_004936578:98,273...113,153
|
|
G |
Cldn3 |
claudin 3 |
|
ISO |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chrNW_004936543:2,952,054...2,953,313
Ensembl chrNW_004936543:2,951,086...2,953,956
|
|
G |
Cldn5 |
claudin 5 |
|
ISO |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chrNW_004936619:3,455,508...3,457,053
Ensembl chrNW_004936619:3,456,166...3,456,822
|
|
G |
Crp |
C-reactive protein |
|
ISO |
protein:increased expression:intestine: |
RGD |
PMID:17981193 |
RGD:5129536 |
NCBI chrNW_004936740:885,855...888,854
Ensembl chrNW_004936740:883,272...890,606
|
|
G |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
|
RGD |
PMID:9117128 |
RGD:11039476 |
NCBI chrNW_004936490:15,142,526...15,146,375
Ensembl chrNW_004936490:15,142,808...15,144,487
|
|
G |
F7 |
coagulation factor VII |
|
ISO |
human protein in a rat model |
RGD |
PMID:22920553 |
RGD:11041662 |
NCBI chrNW_004936472:505,751...515,375
Ensembl chrNW_004936472:505,751...514,339
|
|
G |
Faslg |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:29170412 |
RGD:13792603 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:16557159 |
RGD:401717563 |
NCBI chrNW_004936470:7,765,810...7,770,837
Ensembl chrNW_004936470:7,765,703...7,768,465
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
ISO |
|
RGD |
PMID:22093738 |
RGD:10402181 |
NCBI chrNW_004936472:25,236,728...25,246,585
Ensembl chrNW_004936472:25,236,728...25,246,580
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:19362701 |
RGD:10766423 |
NCBI chrNW_004936492:5,042,353...5,049,216
Ensembl chrNW_004936492:5,042,330...5,049,311
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
|
RGD |
PMID:12095141 PMID:22079846 |
RGD:11522715 RGD:401794136 |
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
|
|
G |
Il6 |
interleukin 6 |
treatment |
ISO |
|
RGD |
PMID:11959089 PMID:22079846 |
RGD:11062110 RGD:401794136 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
|
RGD |
PMID:22777122 |
RGD:10403072 |
NCBI chrNW_004936503:111,722...243,627
Ensembl chrNW_004936503:110,963...241,867
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
ISO |
protein:increased expression:heart, kidney, liver, lung |
RGD |
PMID:22493902 |
RGD:9685194 |
NCBI chrNW_004936561:3,017,471...3,035,481
Ensembl chrNW_004936561:3,016,926...3,035,552
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
|
RGD |
PMID:15001561 |
RGD:13515113 |
NCBI chrNW_004936541:4,157,847...4,178,156
Ensembl chrNW_004936541:4,157,393...4,178,177
|
|
G |
LOC101969421 |
cytochrome P450 1A2 |
treatment |
ISO |
|
RGD |
PMID:22079846 |
RGD:401794136 |
NCBI chrNW_004936471:33,704,616...33,709,455
Ensembl chrNW_004936471:33,703,792...33,709,484
|
|
G |
LOC101976500 |
haptoglobin |
treatment |
ISO |
|
RGD |
PMID:11922743 |
RGD:11041790 |
NCBI chrNW_004936475:21,841,054...21,845,821
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
treatment |
ISO |
|
RGD |
PMID:22079846 |
RGD:401794136 |
NCBI chrNW_004936494:9,537,793...9,541,187
Ensembl chrNW_004936494:9,537,008...9,541,612
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
|
RGD |
PMID:16610051 |
RGD:7777112 |
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:28382390 |
RGD:13440093 |
NCBI chrNW_004936475:19,771,384...19,785,034
Ensembl chrNW_004936475:19,769,488...19,785,311
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1 group H member 4 |
disease_progression |
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:23331901 |
RGD:15042883 |
NCBI chrNW_004936492:13,315,265...13,365,186
Ensembl chrNW_004936492:13,315,265...13,374,034
|
|
G |
Parg |
poly(ADP-ribose) glycohydrolase |
treatment |
ISO |
|
RGD |
PMID:15791006 |
RGD:13514040 |
NCBI chrNW_004936728:428,028...538,413
Ensembl chrNW_004936728:428,028...541,530
|
|
G |
Ppp1r15a |
protein phosphatase 1 regulatory subunit 15A |
|
ISO |
mRNA:increased expression:jejunum (human) |
RGD |
PMID:20965186 |
RGD:9999150 |
NCBI chrNW_004936664:2,910,609...2,914,205
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:15187522 |
RGD:11250409 |
NCBI chrNW_004936469:43,841,989...43,850,322
Ensembl chrNW_004936469:43,841,989...43,850,304
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
treatment |
ISO |
|
RGD |
PMID:22079846 |
RGD:401794136 |
NCBI chrNW_004936599:3,800,142...3,810,583
Ensembl chrNW_004936599:3,801,636...3,809,813
|
|
G |
Serpinc1 |
serpin family C member 1 |
treatment |
ISO |
|
RGD |
PMID:21046505 |
RGD:11035258 |
NCBI chrNW_004936481:13,981,014...13,993,750
Ensembl chrNW_004936481:13,981,019...13,993,634
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
protein:increased activity:plasma (rat) |
RGD |
PMID:12717359 |
RGD:11081012 |
NCBI chrNW_004936543:1,032,543...1,040,956
Ensembl chrNW_004936543:1,032,794...1,039,123
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
treatment |
ISO |
|
RGD |
PMID:27538408 |
RGD:151347179 |
NCBI chrNW_004936530:9,312,965...9,315,593
Ensembl chrNW_004936530:9,312,965...9,316,165
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
|
RGD |
PMID:22079846 |
RGD:401794136 |
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
G |
Traf6 |
TNF receptor associated factor 6 |
|
ISO |
|
RGD |
PMID:27538408 |
RGD:151347179 |
NCBI chrNW_004936533:1,857,685...1,874,973
Ensembl chrNW_004936533:1,857,666...1,876,120
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
ameliorates |
ISO |
associated with mesenteric vascular occlusion; |
RGD |
PMID:18091551 |
RGD:127284848 |
NCBI chrNW_004936476:18,577,825...18,583,675
Ensembl chrNW_004936476:18,574,381...18,583,647
|
|
G |
Vwf |
von Willebrand factor |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:10365842 |
RGD:11080742 |
NCBI chrNW_004936709:1,578,137...1,741,877
Ensembl chrNW_004936709:1,579,096...1,741,754
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
ISO |
|
RGD |
PMID:23010742 |
RGD:13209016 |
NCBI chrNW_004936493:1,762,814...1,824,501
Ensembl chrNW_004936493:1,762,869...1,823,238
|
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
|
ISO |
mRNA:decreased expression:kidney |
RGD |
PMID:20528771 |
RGD:9685432 |
NCBI chrNW_004936470:4,964,526...5,011,808
Ensembl chrNW_004936470:4,965,332...5,011,702
|
|
G |
Acta1 |
actin alpha 1, skeletal muscle |
ameliorates |
ISO |
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chrNW_004936484:20,236,320...20,239,385
Ensembl chrNW_004936484:20,236,320...20,239,430
|
|
G |
Acvr2b |
activin A receptor type 2B |
treatment |
ISO |
human construct in rat model |
RGD |
PMID:27732750 |
RGD:329322881 |
NCBI chrNW_004936473:27,816,366...27,822,555
Ensembl chrNW_004936473:27,815,399...27,822,476
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
treatment |
ISO |
|
RGD |
PMID:22015440 |
RGD:13703100 |
NCBI chrNW_004936532:5,864,851...5,904,005
Ensembl chrNW_004936532:5,864,867...5,904,003
|
|
G |
Adam2 |
ADAM metallopeptidase domain 2 |
|
ISO |
|
RGD |
PMID:11967014 |
RGD:10047130 |
NCBI chrNW_004936675:393,160...451,851
Ensembl chrNW_004936675:397,161...451,153
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
ISO |
|
RGD |
PMID:18272597 |
RGD:9684850 |
NCBI chrNW_004936640:959,405...967,305
Ensembl chrNW_004936640:959,417...968,842
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
ISO |
|
RGD |
PMID:21412771 |
RGD:8695946 |
NCBI chrNW_004936578:3,168,599...3,179,369
Ensembl chrNW_004936578:3,168,331...3,171,928
|
|
G |
Adm |
adrenomedullin |
treatment |
ISO |
protein:increased expression:serum: |
RGD |
PMID:20538296 |
RGD:7364948 |
NCBI chrNW_004936528:8,005,223...8,007,586
Ensembl chrNW_004936528:8,005,189...8,007,643
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
|
ISO |
|
RGD |
PMID:31089212 |
RGD:27226686 |
NCBI chrNW_004936474:26,680,736...26,696,996
Ensembl chrNW_004936474:26,680,676...26,697,214
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
|
RGD |
PMID:22022451 |
RGD:7241603 |
NCBI chrNW_004936558:4,362,693...4,387,705
Ensembl chrNW_004936558:4,362,654...4,390,414
|
|
G |
Anxa1 |
annexin A1 |
treatment |
ISO |
|
RGD |
PMID:20953576 |
RGD:7421585 |
NCBI chrNW_004936503:9,124,314...9,142,372
Ensembl chrNW_004936503:9,124,264...9,142,413
|
|
G |
Anxa5 |
annexin A5 |
|
ISO |
|
RGD |
PMID:21918686 |
RGD:7242028 |
NCBI chrNW_004936662:926,302...959,964
Ensembl chrNW_004936662:925,940...939,451
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
treatment |
ISO |
|
RGD |
PMID:26362957 |
RGD:13703110 |
NCBI chrNW_004936492:14,818,561...14,902,231
Ensembl chrNW_004936492:14,816,623...14,902,132
|
|
G |
Apoa1 |
apolipoprotein A1 |
treatment |
ISO |
|
RGD |
PMID:18535924 |
RGD:7241574 |
NCBI chrNW_004936542:2,111,055...2,112,626
Ensembl chrNW_004936542:2,111,052...2,112,854
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:22768306 |
RGD:10053607 |
NCBI chrNW_004936551:359,134...534,672
Ensembl chrNW_004936551:359,362...532,211
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chrNW_004936664:2,968,103...2,973,652
Ensembl chrNW_004936664:2,967,865...2,973,820
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:18221257 PMID:29285062 |
RGD:13792599 RGD:2293026 |
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
|
ISO |
|
RGD |
PMID:18725957 |
RGD:7241559 |
NCBI chrNW_004936604:551,774...567,014
|
|
G |
Becn1 |
beclin 1 |
treatment |
ISO |
|
RGD |
PMID:26412257 |
RGD:11561958 |
NCBI chrNW_004936490:17,518,100...17,531,126
Ensembl chrNW_004936490:17,517,751...17,531,151
|
|
G |
Bmi1 |
BMI1 proto-oncogene, polycomb ring finger |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chrNW_004936520:5,707,542...5,716,966
Ensembl chrNW_004936520:5,707,778...5,717,024
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:23698117 |
RGD:11561968 |
NCBI chrNW_004936486:18,449,371...18,460,435
Ensembl chrNW_004936486:18,448,494...18,455,927
|
|
G |
C3 |
complement C3 |
treatment |
ISO |
|
RGD |
PMID:19691975 |
RGD:7411689 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
Calca |
calcitonin related polypeptide alpha |
|
ISO |
|
RGD |
PMID:19194162 |
RGD:7204479 |
NCBI chrNW_004936528:3,800,801...3,806,000
Ensembl chrNW_004936528:3,800,577...3,805,004
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Casp7 |
caspase 7 |
|
ISO |
|
RGD |
PMID:17596683 |
RGD:5684536 |
NCBI chrNW_004936486:4,082,664...4,114,942
Ensembl chrNW_004936486:4,088,372...4,114,955
|
|
G |
Ccn1 |
cellular communication network factor 1 |
ameliorates |
ISO |
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chrNW_004936608:152,174...155,123
Ensembl chrNW_004936608:151,838...155,358
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
mRNA,protein:increased expression:kidney |
RGD |
PMID:10966493 |
RGD:7204444 |
NCBI chrNW_004936531:9,572,392...9,575,771
Ensembl chrNW_004936531:9,571,796...9,575,923
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:25993320 |
RGD:11251055 |
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
|
|
G |
Cfb |
complement factor B |
|
ISO |
|
RGD |
PMID:12538716 PMID:16467447 |
RGD:7242709 RGD:7242734 |
NCBI chrNW_004936727:1,595,872...1,602,274
Ensembl chrNW_004936727:1,595,499...1,602,215
|
|
G |
Ciita |
class II major histocompatibility complex transactivator |
|
ISO |
|
RGD |
PMID:14569092 |
RGD:7242896 |
NCBI chrNW_004936530:9,033,510...9,073,341
|
|
G |
Cited1 |
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1 |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chrNW_004936762:1,387,354...1,392,955
Ensembl chrNW_004936762:1,387,346...1,391,967
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
ameliorates |
ISO |
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chrNW_004936490:11,448,552...11,465,836
Ensembl chrNW_004936490:11,448,654...11,464,444
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
ameliorates |
ISO |
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chrNW_004936506:8,886,494...8,923,921
Ensembl chrNW_004936506:8,886,494...8,923,930
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:19196448 PMID:23143303 |
RGD:7257565 RGD:7257570 |
NCBI chrNW_004936704:1,372,137...1,393,355
Ensembl chrNW_004936704:1,378,103...1,393,542
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
ISO |
|
RGD |
PMID:23143303 |
RGD:7257565 |
NCBI chrNW_004936504:4,898,947...4,927,195
Ensembl chrNW_004936504:4,898,945...4,928,923
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
|
ISO |
|
RGD |
PMID:9407517 PMID:22189844 |
RGD:7204675 RGD:7204727 |
NCBI chrNW_004936631:484,356...489,643
Ensembl chrNW_004936631:484,356...489,643
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:29073721 |
RGD:13825150 |
NCBI chrNW_004936469:39,794,613...39,798,448
Ensembl chrNW_004936469:39,794,584...39,798,459
|
|
G |
Daxx |
death domain associated protein |
|
ISO |
protein:increased expression:kidney: |
RGD |
PMID:18480747 |
RGD:9587836 |
NCBI chrNW_004936476:25,546,091...25,550,390
Ensembl chrNW_004936476:25,546,036...25,550,392
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
ISO |
protein:increased expression:kidney (mouse) |
RGD |
PMID:31383731 |
RGD:151347540 |
NCBI chrNW_004936837:523,227...538,799
Ensembl chrNW_004936837:523,266...538,833
|
|
G |
Dhfr |
dihydrofolate reductase |
treatment |
ISO |
mRNA,protein:decreased expression:kidney: |
RGD |
PMID:18408363 |
RGD:11040540 |
NCBI chrNW_004936469:67,962...83,116
|
|
G |
Drd3 |
dopamine receptor D3 |
treatment |
ISO |
|
RGD |
PMID:25989500 |
RGD:13506961 |
NCBI chrNW_004936536:1,580,732...1,616,726
Ensembl chrNW_004936536:1,580,732...1,616,725
|
|
G |
Eed |
embryonic ectoderm development |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chrNW_004936498:14,050,731...14,082,410
Ensembl chrNW_004936498:14,051,045...14,083,570
|
|
G |
Egln1 |
egl-9 family hypoxia inducible factor 1 |
|
ISO |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chrNW_004936484:19,343,770...19,386,087
|
|
G |
Egln3 |
egl-9 family hypoxia inducible factor 3 |
|
ISO |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chrNW_004936494:8,240,272...8,267,487
Ensembl chrNW_004936494:8,238,858...8,267,606
|
|
G |
Eng |
endoglin |
|
ISO |
mRNA, protein:increased expression:kidney (rat) |
RGD |
PMID:16751653 |
RGD:7248779 |
NCBI chrNW_004936487:15,467,165...15,499,180
Ensembl chrNW_004936487:15,467,835...15,477,488
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
protein:altered localization:kidney (rat) |
RGD |
PMID:23936185 |
RGD:7257563 |
NCBI chrNW_004936492:696,982...778,132
Ensembl chrNW_004936492:696,960...778,138
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:19961832 PMID:25581532 |
RGD:10401077 RGD:11041698 |
NCBI chrNW_004936543:742,722...745,332
Ensembl chrNW_004936543:743,537...745,343
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chrNW_004936527:5,024,077...5,069,152
Ensembl chrNW_004936527:5,024,068...5,063,939
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:25883098 |
RGD:11341735 |
NCBI chrNW_004936537:4,637,028...4,647,915
Ensembl chrNW_004936537:4,636,667...4,647,916
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Faslg |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
Fcgr1a |
Fc fragment of IgG receptor Ia |
treatment |
ISO |
|
RGD |
PMID:22402584 |
RGD:9685699 |
NCBI chrNW_004936580:115,552...144,970
Ensembl chrNW_004936580:115,450...145,785
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
mRNA,protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chrNW_004936576:1,322,406...1,329,743
|
|
G |
Fgb |
fibrinogen beta chain |
treatment |
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chrNW_004936576:1,306,076...1,313,485
Ensembl chrNW_004936576:1,306,109...1,313,386
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
exacerbates ameliorates |
ISO |
protein:increased phosphorylation:kidney (mouse) |
RGD |
PMID:20591940 PMID:22688984 PMID:29344510 PMID:32523960 |
RGD:155663667 RGD:155782882 RGD:155782904 RGD:155882537 |
NCBI chrNW_004936486:10,506,680...10,606,272
Ensembl chrNW_004936486:10,507,097...10,602,019
|
|
G |
Fgg |
fibrinogen gamma chain |
|
ISO |
mRNA,protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chrNW_004936576:1,343,657...1,352,085
Ensembl chrNW_004936576:1,343,661...1,352,143
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
|
RGD |
PMID:11352844 |
RGD:7205629 |
NCBI chrNW_004936586:1,708,803...1,773,372
Ensembl chrNW_004936586:1,708,684...1,773,383
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
|
RGD |
PMID:19095962 |
RGD:7242184 |
NCBI chrNW_004936488:4,384,710...4,388,118
Ensembl chrNW_004936488:4,384,705...4,388,122
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
ISO |
|
RGD |
PMID:17250641 |
RGD:2307361 |
NCBI chrNW_004936809:1,269,900...1,285,853
Ensembl chrNW_004936809:1,269,914...1,285,889
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
protein:increased expression:kidney: |
RGD |
PMID:20332418 |
RGD:9685723 |
NCBI chrNW_004936694:2,051,362...2,053,812
Ensembl chrNW_004936694:2,051,325...2,053,818
|
|
G |
Glo1 |
glyoxalase I |
|
ISO |
|
RGD |
PMID:19211689 |
RGD:7242566 |
NCBI chrNW_004936476:20,910,696...20,928,583
Ensembl chrNW_004936476:20,910,629...20,930,295
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
ISO |
protein:decreased expression:kidney mRNA:decreased expression:kidney |
RGD |
PMID:22442209 PMID:37033969 |
RGD:401827821 RGD:401827906 |
NCBI chrNW_004936647:3,904,787...3,914,223
Ensembl chrNW_004936647:3,906,113...3,913,498
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
ISO |
|
RGD |
PMID:24630969 |
RGD:10401866 |
NCBI chrNW_004936792:531,076...579,083
Ensembl chrNW_004936792:531,756...579,166
|
|
G |
Has1 |
hyaluronan synthase 1 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chrNW_004937026:125,622...132,141
Ensembl chrNW_004937026:125,881...135,235
|
|
G |
Has2 |
hyaluronan synthase 2 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chrNW_004936470:25,418,069...25,443,332
Ensembl chrNW_004936470:25,418,063...25,444,634
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
protein:increased expression:urine: |
RGD |
PMID:23019274 PMID:23085062 PMID:23552495 |
RGD:7244372 RGD:7245489 RGD:7245495 |
NCBI chrNW_004936515:6,030,402...6,051,161
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
severity treatment |
ISO |
|
RGD |
PMID:17519789 PMID:22432008 |
RGD:1626334 RGD:9068883 |
NCBI chrNW_004936495:5,770,988...5,816,157
Ensembl chrNW_004936495:5,770,669...5,816,157
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:21291499 |
RGD:10755580 |
NCBI chrNW_004936492:5,042,353...5,049,216
Ensembl chrNW_004936492:5,042,330...5,049,311
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
|
ISO |
protein:increased expression:kidney (rat) |
RGD |
PMID:23102208 |
RGD:10402775 |
NCBI chrNW_004936470:7,927,734...7,950,805
Ensembl chrNW_004936470:7,928,095...7,933,337
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
|
RGD |
PMID:7569112 |
RGD:7242788 |
NCBI chrNW_004936542:7,577,192...7,581,598
Ensembl chrNW_004936542:7,577,149...7,581,923
|
|
G |
Hyal1 |
hyaluronidase 1 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chrNW_004936529:1,838,212...1,842,399
Ensembl chrNW_004936529:1,838,676...1,841,188
|
|
G |
Hyal2 |
hyaluronidase 2 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chrNW_004936529:1,845,445...1,851,106
Ensembl chrNW_004936529:1,845,763...1,851,252
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
|
RGD |
PMID:28355607 |
RGD:14975115 |
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
|
|
G |
Igf1r |
insulin like growth factor 1 receptor |
|
ISO |
mRNA: increased expression: kidney: 3 and 5 days post ischemia |
RGD |
PMID:10990448 |
RGD:7242905 |
NCBI chrNW_004936483:4,563,995...4,860,231
Ensembl chrNW_004936483:4,564,512...4,852,925
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
treatment |
ISO |
|
RGD |
PMID:19546526 |
RGD:7495779 |
NCBI chrNW_004936785:358,128...406,751
Ensembl chrNW_004936785:356,168...406,773
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:24079335 PMID:28664613 |
RGD:14975137 RGD:7364864 |
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il12b |
interleukin 12B |
ameliorates |
ISO |
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chrNW_004936515:4,056,214...4,066,121
Ensembl chrNW_004936515:4,056,214...4,065,076
|
|
G |
Il18 |
interleukin 18 |
treatment |
ISO |
|
RGD |
PMID:22089199 |
RGD:8655971 |
NCBI chrNW_004936612:2,306,963...2,325,086
Ensembl chrNW_004936612:2,306,875...2,325,189
|
|
G |
Il1b |
interleukin 1 beta |
ameliorates |
ISO |
|
RGD |
PMID:20030532 PMID:24920753 |
RGD:329845564 RGD:7175501 |
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
mouse model treated with human protein rat model treated with human protein |
RGD |
PMID:9555664 PMID:16849996 PMID:18363573 |
RGD:6907101 RGD:6907359 RGD:6909149 |
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
|
|
G |
Il6 |
interleukin 6 |
ameliorates |
ISO |
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Inhbb |
inhibin subunit beta B |
|
ISO |
protein:increased expression:serum (rat) |
RGD |
PMID:27732750 |
RGD:329322881 |
NCBI chrNW_004936469:50,186,036...50,191,455
Ensembl chrNW_004936469:50,186,036...50,191,461
|
|
G |
Itgb2 |
integrin subunit beta 2 |
|
ISO |
Associated with renal transplant patients |
RGD |
PMID:11007822 PMID:20504838 |
RGD:6907049 RGD:6907073 |
NCBI chrNW_004936778:1,286,475...1,311,184
Ensembl chrNW_004936778:1,286,341...1,311,194
|
|
G |
Kcnj11 |
potassium inwardly rectifying channel subfamily J member 11 |
|
ISO |
protein:decreased expression:kidney |
RGD |
PMID:21250976 |
RGD:7297045 |
NCBI chrNW_004936528:1,685,015...1,688,220
Ensembl chrNW_004936528:1,685,924...1,687,096
|
|
G |
Kl |
klotho |
treatment |
ISO |
mRNA,protein:decreased expression:renal tubule: |
RGD |
PMID:16204278 |
RGD:10403064 |
NCBI chrNW_004936472:27,604,681...27,649,613
Ensembl chrNW_004936472:27,604,517...27,650,086
|
|
G |
Kmt2a |
lysine methyltransferase 2A |
|
ISO |
protein:increased expression:kidney (mouse) |
RGD |
PMID:31570196 |
RGD:155888490 |
NCBI chrNW_004936542:3,480,071...3,566,823
Ensembl chrNW_004936542:3,391,774...3,562,147
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO |
mRNA,protein:increased expression:kidney,urine mRNA,protein:increased expression:kidney: protein:increased expression:urine: |
RGD |
PMID:20181666 PMID:23085062 PMID:23364806 PMID:27800610 |
RGD:126779563 RGD:126790572 RGD:7245469 RGD:7245489 |
NCBI chrNW_004936487:15,721,752...15,725,396
Ensembl chrNW_004936487:15,721,684...15,728,221
|
|
G |
Lep |
leptin |
resistance |
ISO |
|
RGD |
PMID:22969992 |
RGD:6909133 |
NCBI chrNW_004936479:15,394,966...15,411,334
Ensembl chrNW_004936479:15,394,966...15,411,334
|
|
G |
Lgals3 |
galectin 3 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:10980121 |
RGD:9685228 |
NCBI chrNW_004936697:20,861...38,568
Ensembl chrNW_004936697:27,145...38,586
|
|
G |
LOC101954950 |
aromatase |
treatment |
ISO |
|
RGD |
PMID:23552495 |
RGD:7244372 |
NCBI chrNW_004936471:13,107,603...13,136,910
Ensembl chrNW_004936471:13,107,603...13,136,910
|
|
G |
LOC101961846 |
neutrophil elastase |
treatment |
ISO |
|
RGD |
PMID:16980042 |
RGD:10450580 |
NCBI chrNW_004936588:345,678...347,420
Ensembl chrNW_004936588:345,678...347,413
|
|
G |
LOC101966907 |
histone H2AX |
treatment |
ISO |
|
RGD |
PMID:23726287 |
RGD:8693706 |
NCBI chrNW_004936542:4,046,930...4,049,017
Ensembl chrNW_004936542:4,047,915...4,048,346
|
|
G |
LOC101968920 |
eotaxin |
treatment |
ISO |
|
RGD |
PMID:22160777 |
RGD:7247742 |
NCBI chrNW_004936538:835,436...848,907
Ensembl chrNW_004936538:835,859...837,710 Ensembl chrNW_004936538:835,859...837,710
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
|
RGD |
PMID:21680852 |
RGD:6893484 |
NCBI chrNW_004936541:4,157,847...4,178,156
Ensembl chrNW_004936541:4,157,393...4,178,177
|
|
G |
LOC101972352 |
frataxin, mitochondrial |
ameliorates |
ISO |
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chrNW_004936882:62,618...95,663
Ensembl chrNW_004936882:74,897...95,890
|
|
G |
Map1lc3a |
microtubule associated protein 1 light chain 3 alpha |
treatment |
ISO |
|
RGD |
PMID:20075199 PMID:26412257 |
RGD:11561916 RGD:11561958 |
NCBI chrNW_004936561:6,104,748...6,106,348
Ensembl chrNW_004936561:6,104,742...6,106,699
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
treatment |
ISO |
|
RGD |
PMID:23952292 |
RGD:10412647 |
NCBI chrNW_004936560:3,988,696...4,197,953
Ensembl chrNW_004936560:3,989,420...4,197,501
|
|
G |
Mc1r |
melanocortin 1 receptor |
|
ISO |
protein:decreased expression:kidney outer medulla |
RGD |
PMID:18790174 |
RGD:5687322 |
NCBI chrNW_004936641:193,885...198,730
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
protein:increased activity:kidney |
RGD |
PMID:18055546 PMID:22950848 |
RGD:6909167 RGD:7174699 |
NCBI chrNW_004936490:4,809,773...4,819,070
Ensembl chrNW_004936490:4,809,631...4,819,070
|
|
G |
Muc1 |
mucin 1, cell surface associated |
treatment |
ISO |
|
RGD |
PMID:22019164 |
RGD:7245959 |
NCBI chrNW_004936580:4,691,870...4,694,092
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
mRNA:increased expression:kidney (rat) |
RGD |
PMID:17220792 |
RGD:7207777 |
NCBI chrNW_004936470:20,480,844...20,485,955
Ensembl chrNW_004936470:20,480,829...20,485,965
|
|
G |
Ndufb8 |
NADH:ubiquinone oxidoreductase subunit B8 |
|
ISO |
|
RGD |
PMID:22160772 PMID:24096033 |
RGD:13801197 RGD:13801199 |
NCBI chrNW_004936600:5,122,004...5,126,776
Ensembl chrNW_004936600:5,116,423...5,129,334
|
|
G |
Nes |
nestin |
|
ISO |
|
RGD |
PMID:24503548 |
RGD:11570523 |
NCBI chrNW_004936580:5,837,949...5,847,499
Ensembl chrNW_004936580:5,837,936...5,847,020
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
treatment |
ISO |
|
RGD |
PMID:31089916 |
RGD:155882543 |
NCBI chrNW_004936509:6,589,967...6,621,171
Ensembl chrNW_004936509:6,590,630...6,620,262
|
|
G |
Nos2 |
nitric oxide synthase 2 |
treatment |
ISO |
|
RGD |
PMID:18408363 |
RGD:11040540 |
NCBI chrNW_004936538:4,052,277...4,097,051
Ensembl chrNW_004936538:4,052,448...4,097,051
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
|
RGD |
PMID:18408363 PMID:29291552 |
RGD:11040540 RGD:13504682 |
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
|
|
G |
Nox1 |
NADPH oxidase 1 |
treatment |
ISO |
|
RGD |
PMID:34244746 |
RGD:329955363 |
NCBI chrNW_004936584:6,023,960...6,040,041
Ensembl chrNW_004936584:6,024,008...6,039,866
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
|
RGD |
PMID:20471588 |
RGD:7247717 |
NCBI chrNW_004936474:671,362...673,610
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:21545725 |
RGD:11035217 |
NCBI chrNW_004936475:19,771,384...19,785,034
Ensembl chrNW_004936475:19,769,488...19,785,311
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4 group A member 1 |
severity |
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:22343121 |
RGD:14700869 |
NCBI chrNW_004936512:9,486,096...9,508,338
Ensembl chrNW_004936512:9,499,754...9,508,423
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
|
RGD |
PMID:12531391 |
RGD:2317150 |
NCBI chrNW_004936602:3,411,106...3,418,826
Ensembl chrNW_004936602:3,413,282...3,418,831
|
|
G |
Pax2 |
paired box 2 |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:12444203 |
RGD:727468 |
NCBI chrNW_004936600:4,850,594...4,939,010
Ensembl chrNW_004936600:4,850,552...4,928,214
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
mRNA,protein:increased expression:tubule, S3 segment: |
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chrNW_004936492:2,353,840...2,368,573
Ensembl chrNW_004936492:2,353,841...2,368,573
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chrNW_004936482:16,804,129...16,853,539
Ensembl chrNW_004936482:16,807,569...16,853,587
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:10550325 PMID:12819032 |
RGD:1580850 RGD:8554477 |
NCBI chrNW_004936504:4,762,251...4,799,789
Ensembl chrNW_004936504:4,762,184...4,799,829
|
|
G |
Peg10 |
paternally expressed 10 |
|
ISO |
mRNA:increased expression:kidney (mouse) |
RGD |
PMID:16778176 |
RGD:401851077 |
NCBI chrNW_004936585:5,437,807...5,451,185
Ensembl chrNW_004936585:5,441,493...5,443,868
|
|
G |
Pkd2 |
polycystin 2, transient receptor potential cation channel |
|
ISO |
protein:increased expression:kidney (rat) |
RGD |
PMID:12454224 |
RGD:1580868 |
NCBI chrNW_004936905:76,781...128,995
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
treatment |
ISO |
|
RGD |
PMID:24918615 |
RGD:10059636 |
NCBI chrNW_004936477:4,881,230...5,488,208
Ensembl chrNW_004936477:5,199,881...5,488,226
|
|
G |
Ptgis |
prostaglandin I2 synthase |
|
ISO |
mRNA:increased expression:kidney (mouse) |
RGD |
PMID:30413885 |
RGD:401959745 |
NCBI chrNW_004936514:4,775,884...4,814,574
Ensembl chrNW_004936514:4,791,031...4,812,027
|
|
G |
Rnls |
renalase, FAD dependent amine oxidase |
|
ISO |
mRNA,protein:decreased expression:kidney,plasma: |
RGD |
PMID:23393318 |
RGD:7327166 |
NCBI chrNW_004936735:659,826...1,048,135
|
|
G |
Serpinc1 |
serpin family C member 1 |
severity |
ISO |
|
RGD |
PMID:26108065 |
RGD:11354006 |
NCBI chrNW_004936481:13,981,014...13,993,750
Ensembl chrNW_004936481:13,981,019...13,993,634
|
|
G |
Serpine1 |
serpin family E member 1 |
ameliorates |
ISO |
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chrNW_004936543:1,032,543...1,040,956
Ensembl chrNW_004936543:1,032,794...1,039,123
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:24744439 |
RGD:12859042 |
NCBI chrNW_004936527:10,033,095...10,042,713
Ensembl chrNW_004936527:10,033,299...10,042,599
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
ISO |
|
RGD |
PMID:22324445 |
RGD:9495930 |
NCBI chrNW_004936521:10,296,097...10,316,673
Ensembl chrNW_004936521:10,296,097...10,322,215
|
|
G |
Six2 |
SIX homeobox 2 |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chrNW_004936508:7,047,563...7,051,129
Ensembl chrNW_004936508:7,047,304...7,051,732
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
|
ISO |
|
RGD |
PMID:21835768 |
RGD:7243877 |
NCBI chrNW_004936489:11,534,095...11,556,759
Ensembl chrNW_004936489:11,534,095...11,556,745
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
|
ISO |
|
RGD |
PMID:21835768 |
RGD:7243877 |
NCBI chrNW_004936489:11,605,403...11,627,786
Ensembl chrNW_004936489:11,594,480...11,627,786
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
ISO |
protein:decreased expression:renal proximal tubule, brush border membrane (rat) |
RGD |
PMID:15775707 |
RGD:2311304 |
NCBI chrNW_004936597:1,667,700...1,684,533
Ensembl chrNW_004936597:1,667,569...1,684,539
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
|
ISO |
|
RGD |
PMID:12819032 |
RGD:1580850 |
NCBI chrNW_004936561:3,826,802...3,844,406
Ensembl chrNW_004936561:3,825,787...3,844,483
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
severity |
ISO |
|
RGD |
PMID:12709397 |
RGD:7244143 |
NCBI chrNW_004936646:1,297,530...1,312,508
Ensembl chrNW_004936646:1,296,290...1,312,157
|
|
G |
Suz12 |
SUZ12 polycomb repressive complex 2 subunit |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chrNW_004936538:2,921,987...2,971,521
Ensembl chrNW_004936538:2,921,719...2,971,552
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
|
ISO |
|
RGD |
PMID:11796005 |
RGD:11062062 |
NCBI chrNW_004936506:10,103,120...10,172,800
Ensembl chrNW_004936506:10,103,139...10,171,863
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
ameliorates |
ISO |
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chrNW_004936661:3,742,080...3,758,266
Ensembl chrNW_004936661:3,742,066...3,758,272
|
|
G |
Tlr2 |
toll like receptor 2 |
treatment severity |
ISO |
|
RGD |
PMID:11801667 PMID:20130923 PMID:22750071 PMID:23023072 PMID:23239000 |
RGD:7207892 RGD:7207894 RGD:7207896 RGD:7240552 RGD:7241087 |
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
|
|
G |
Tlr4 |
toll like receptor 4 |
treatment |
ISO |
|
RGD |
PMID:11801667 PMID:20130923 PMID:23239000 |
RGD:7207892 RGD:7240552 RGD:7241087 |
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
|
|
G |
Tnf |
tumor necrosis factor |
ameliorates |
ISO |
protein:increased expression:serum |
RGD |
PMID:19925291 PMID:24920753 |
RGD:2315112 RGD:329845564 |
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:22728466 |
RGD:7245543 |
NCBI chrNW_004936709:1,407,327...1,421,448
Ensembl chrNW_004936709:1,407,278...1,421,921
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:20164827 |
RGD:7240507 |
NCBI chrNW_004936748:785,491...802,791
Ensembl chrNW_004936748:785,455...803,048
|
|
G |
Vwf |
von Willebrand factor |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:12684225 |
RGD:11080744 |
NCBI chrNW_004936709:1,578,137...1,741,877
Ensembl chrNW_004936709:1,579,096...1,741,754
|
|
G |
Wt1 |
WT1 transcription factor |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chrNW_004936533:5,411,949...5,459,693
Ensembl chrNW_004936533:5,411,848...5,459,693
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
ISO |
associated with Diabetes Mellitus, Type 2 |
RGD |
PMID:20616412 PMID:22995295 |
RGD:7247637 RGD:7247695 |
NCBI chrNW_004936493:1,762,814...1,824,501
Ensembl chrNW_004936493:1,762,869...1,823,238
|
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
treatment |
ISO |
|
RGD |
PMID:36495512 |
RGD:401717522 |
NCBI chrNW_004936470:7,765,810...7,770,837
Ensembl chrNW_004936470:7,765,703...7,768,465
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
ISO |
|
RGD |
PMID:23762489 |
RGD:8695935 |
NCBI chrNW_004936578:3,168,599...3,179,369
Ensembl chrNW_004936578:3,168,331...3,171,928
|
|
G |
Adm |
adrenomedullin |
treatment |
ISO |
mRNA,protein:increased expression:liver,plasma: |
RGD |
PMID:19212187 |
RGD:7364958 |
NCBI chrNW_004936528:8,005,223...8,007,586
Ensembl chrNW_004936528:8,005,189...8,007,643
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:21431875 |
RGD:10402078 |
NCBI chrNW_004936727:1,418,342...1,422,005
Ensembl chrNW_004936727:1,418,799...1,422,147
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
treatment |
ISO |
protein:altered expression:liver (mouse) protein:altered expression:liver (rat) |
RGD |
PMID:29589772 PMID:30671488 |
RGD:14975297 RGD:15036807 |
NCBI chrNW_004936558:4,362,693...4,387,705
Ensembl chrNW_004936558:4,362,654...4,390,414
|
|
G |
Atf6 |
activating transcription factor 6 |
ameliorates |
ISO |
|
RGD |
PMID:34144219 |
RGD:329812011 |
NCBI chrNW_004937131:170,649...183,942
|
|
G |
Atg13 |
autophagy related 13 |
ameliorates |
ISO |
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chrNW_004936562:2,424,398...2,473,103
Ensembl chrNW_004936562:2,423,001...2,473,232
|
|
G |
Atg16l1 |
autophagy related 16 like 1 |
ameliorates |
ISO |
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chrNW_004936525:3,973,574...4,010,442
Ensembl chrNW_004936525:3,972,558...4,010,514
|
|
G |
Atg4d |
autophagy related 4D cysteine peptidase |
ameliorates |
ISO |
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chrNW_004936659:823,318...830,642
Ensembl chrNW_004936659:823,172...830,521
|
|
G |
Atg7 |
autophagy related 7 |
ameliorates |
ISO |
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chrNW_004936602:1,938,720...2,179,239
Ensembl chrNW_004936602:1,935,507...2,179,256
|
|
G |
Bad |
BCL2 associated agonist of cell death |
treatment |
ISO |
associated with Non-alcoholic Fatty Liver Disease mRNA:increased expression:liver |
RGD |
PMID:22647552 PMID:22847887 |
RGD:10053673 RGD:10053710 |
NCBI chrNW_004936599:4,924,349...4,933,683
Ensembl chrNW_004936599:4,924,789...4,933,368
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
ameliorates treatment |
ISO |
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:21092002 PMID:22647552 PMID:22847887 PMID:34144219 |
RGD:10053673 RGD:10053710 RGD:329812011 RGD:5134995 |
NCBI chrNW_004936664:2,968,103...2,973,652
Ensembl chrNW_004936664:2,967,865...2,973,820
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment ameliorates |
ISO |
associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:21092002 PMID:22847887 PMID:34144219 |
RGD:10053710 RGD:329812011 RGD:5134995 |
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G |
Bcl2l1 |
BCL2 like 1 |
treatment |
ISO |
associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22847887 |
RGD:10053710 |
NCBI chrNW_004936485:18,654,046...18,707,324
|
|
G |
Becn1 |
beclin 1 |
ameliorates |
ISO |
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chrNW_004936490:17,518,100...17,531,126
Ensembl chrNW_004936490:17,517,751...17,531,151
|
|
G |
Bid |
BH3 interacting domain death agonist |
ameliorates |
ISO |
|
RGD |
PMID:17893612 |
RGD:408346749 |
NCBI chrNW_004936807:708,340...750,127
Ensembl chrNW_004936807:708,276...750,093
|
|
G |
C3 |
complement C3 |
treatment |
ISO |
|
RGD |
PMID:19854450 |
RGD:11040888 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
Casp3 |
caspase 3 |
ameliorates |
ISO |
|
RGD |
PMID:34144219 |
RGD:329812011 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Casp8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:15300206 PMID:23423194 |
RGD:14695087 RGD:8661760 |
NCBI chrNW_004936726:554,627...596,334
Ensembl chrNW_004936726:554,758...595,922
|
|
G |
Casp9 |
caspase 9 |
treatment ameliorates |
ISO |
|
RGD |
PMID:23364428 PMID:34144219 |
RGD:13782358 RGD:329812011 |
NCBI chrNW_004936474:3,178,097...3,196,130
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
treatment severity |
ISO |
|
RGD |
PMID:28623253 |
RGD:14995305 |
NCBI chrNW_004936490:253,279...259,947
Ensembl chrNW_004936490:253,034...259,965
|
|
G |
Ccn1 |
cellular communication network factor 1 |
ameliorates |
ISO |
|
RGD |
PMID:34144219 |
RGD:329812011 |
NCBI chrNW_004936608:152,174...155,123
Ensembl chrNW_004936608:151,838...155,358
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:22564590 |
RGD:7183676 |
NCBI chrNW_004936531:9,572,392...9,575,771
Ensembl chrNW_004936531:9,571,796...9,575,923
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:14741776 |
RGD:8547795 |
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
|
|
G |
Cs |
citrate synthase |
|
ISO |
|
RGD |
PMID:25416448 |
RGD:13504849 |
NCBI chrNW_004936646:676,926...704,988
Ensembl chrNW_004936646:678,307...692,777
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
ameliorates treatment |
ISO |
|
RGD |
PMID:18041715 PMID:34400126 |
RGD:27095942 RGD:329902072 |
NCBI chrNW_004936676:60,869...63,028
Ensembl chrNW_004936676:60,621...63,106
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
ameliorates |
ISO |
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chrNW_004936676:33,580...40,323
Ensembl chrNW_004936676:32,128...40,329
|
|
G |
Ddit3 |
DNA damage inducible transcript 3 |
ameliorates |
ISO |
|
RGD |
PMID:34144219 |
RGD:329812011 |
NCBI chrNW_004936646:1,665,019...1,669,212
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
ameliorates |
ISO |
|
RGD |
PMID:34144219 |
RGD:329812011 |
NCBI chrNW_004936712:413,602...454,443
Ensembl chrNW_004936712:414,446...454,449
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:25769561 |
RGD:15090809 |
NCBI chrNW_004936543:742,722...745,332
Ensembl chrNW_004936543:743,537...745,343
|
|
G |
Epor |
erythropoietin receptor |
|
ISO |
protein:increased phosphorylation:liver: |
RGD |
PMID:25769561 |
RGD:15090809 |
NCBI chrNW_004936659:1,468,391...1,473,880
Ensembl chrNW_004936659:1,468,634...1,473,880
|
|
G |
F3 |
coagulation factor III, tissue factor |
treatment |
ISO |
|
RGD |
PMID:11750579 |
RGD:11341708 |
NCBI chrNW_004936537:4,637,028...4,647,915
Ensembl chrNW_004936537:4,636,667...4,647,916
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
ISO |
|
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chrNW_004936599:633,501...639,412
Ensembl chrNW_004936599:633,330...639,456
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
protein:increased expression:liver |
RGD |
PMID:16222447 PMID:17235585 PMID:18561025 |
RGD:14700680 RGD:1600351 RGD:2290283 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Faslg |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:18561025 |
RGD:14700680 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:23503399 |
RGD:9685021 |
NCBI chrNW_004936576:1,322,406...1,329,743
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
|
RGD |
PMID:12651615 |
RGD:7205470 |
NCBI chrNW_004936586:1,708,803...1,773,372
Ensembl chrNW_004936586:1,708,684...1,773,383
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
treatment |
ISO |
|
RGD |
PMID:13678701 PMID:22564598 |
RGD:329970282 RGD:329970285 |
NCBI chrNW_004936470:7,765,810...7,770,837
Ensembl chrNW_004936470:7,765,703...7,768,465
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
treatment |
ISO |
associated with nonalcoholic fatty liver disease |
RGD |
PMID:28807209 |
RGD:13792730 |
NCBI chrNW_004936536:6,730,070...6,893,818
Ensembl chrNW_004936536:6,730,062...6,894,303
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO |
mRNA, protein:increased expression, altered localization:serum, hepatocyte, cytoplasm protein:increased oxidation:liver |
RGD |
PMID:21431875 PMID:22514737 PMID:24578610 |
RGD:10402068 RGD:10402078 RGD:10402175 |
NCBI chrNW_004936472:25,236,728...25,246,585
Ensembl chrNW_004936472:25,236,728...25,246,580
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:20446775 |
RGD:10755725 |
NCBI chrNW_004936492:5,042,353...5,049,216
Ensembl chrNW_004936492:5,042,330...5,049,311
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
associated with Intestinal Reperfusion Injury;protein:increased expression:liver |
RGD |
PMID:7884306 PMID:8780571 |
RGD:11520784 RGD:14402044 |
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
severity |
ISO |
|
RGD |
PMID:28938192 |
RGD:14985248 |
NCBI chrNW_004936483:15,845,777...15,864,341
Ensembl chrNW_004936483:15,845,792...15,864,341
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
treatment |
ISO |
|
RGD |
PMID:22381173 |
RGD:12791280 |
NCBI chrNW_004936809:1,280,254...1,306,964
Ensembl chrNW_004936809:1,257,654...1,301,813
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:21911118 |
RGD:7364839 |
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il18 |
interleukin 18 |
treatment |
ISO |
|
RGD |
PMID:14999688 PMID:25919765 |
RGD:14696667 RGD:14696668 |
NCBI chrNW_004936612:2,306,963...2,325,086
Ensembl chrNW_004936612:2,306,875...2,325,189
|
|
G |
Il18bp |
interleukin 18 binding protein |
|
ISO |
mRNA,protein:increased expression:liver |
RGD |
PMID:25919765 |
RGD:14696667 |
NCBI chrNW_004936498:1,353,569...1,358,312
Ensembl chrNW_004936498:1,355,749...1,361,117
|
|
G |
Il1a |
interleukin 1 alpha |
treatment |
ISO |
mRNA:increased expression:lung protein:increased expression:serum |
RGD |
PMID:9840148 PMID:19283466 PMID:19595018 |
RGD:11059517 RGD:2314952 RGD:6907377 |
NCBI chrNW_004936783:1,210,715...1,218,315
Ensembl chrNW_004936783:1,210,809...1,218,315
|
|
G |
Il1b |
interleukin 1 beta |
treatment ameliorates |
ISO |
associated with Cholestasis |
RGD |
PMID:21468628 PMID:32155285 PMID:34400126 |
RGD:155260323 RGD:329902072 RGD:7175318 |
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO |
rat model treated with human protein |
RGD |
PMID:9000676 PMID:12451245 |
RGD:6909138 RGD:8551710 |
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
|
|
G |
Il6 |
interleukin 6 |
ameliorates treatment |
ISO |
|
RGD |
PMID:24752458 PMID:32155285 PMID:34144219 PMID:34400126 |
RGD:11062134 RGD:155260323 RGD:329812011 RGD:329902072 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Irf8 |
interferon regulatory factor 8 |
ameliorates |
ISO |
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chrNW_004936641:2,608,109...2,622,446
Ensembl chrNW_004936641:2,608,100...2,622,409
|
|
G |
Itgam |
integrin subunit alpha M |
exacerbates treatment |
ISO |
protein:increased expression:neutrophil (rat) |
RGD |
PMID:8387952 PMID:11447039 |
RGD:329901847 RGD:329901849 |
NCBI chrNW_004936543:8,460,526...8,508,524
Ensembl chrNW_004936543:8,461,307...8,508,524
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
ISO |
|
RGD |
PMID:22288937 |
RGD:10403073 |
NCBI chrNW_004936503:111,722...243,627
Ensembl chrNW_004936503:110,963...241,867
|
|
G |
Lamp2 |
lysosomal associated membrane protein 2 |
ameliorates |
ISO |
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chrNW_004936479:9,584,221...9,622,330
Ensembl chrNW_004936479:9,584,221...9,610,420
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:12134092 |
RGD:9685192 |
NCBI chrNW_004936561:3,017,471...3,035,481
Ensembl chrNW_004936561:3,016,926...3,035,552
|
|
G |
LOC101960095 |
antileukoproteinase |
|
ISO |
|
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chrNW_004936514:7,618,382...7,620,790
Ensembl chrNW_004936514:7,618,261...7,620,912
|
|
G |
LOC101961846 |
neutrophil elastase |
|
ISO |
|
RGD |
PMID:10588515 |
RGD:10450560 |
NCBI chrNW_004936588:345,678...347,420
Ensembl chrNW_004936588:345,678...347,413
|
|
G |
LOC101964013 |
mucin-17 |
|
ISO |
mRNA, protein:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chrNW_004936543:976,794...987,062
|
|
G |
LOC101964209 |
C-C chemokine receptor type 1 |
ameliorates |
ISO |
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chrNW_004936596:177,774...183,186
Ensembl chrNW_004936596:177,812...183,186
|
|
G |
LOC101966907 |
histone H2AX |
treatment |
ISO |
|
RGD |
PMID:23792534 |
RGD:8693718 |
NCBI chrNW_004936542:4,046,930...4,049,017
Ensembl chrNW_004936542:4,047,915...4,048,346
|
|
G |
LOC101969148 |
cytochrome P450 1A1 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chrNW_004936471:33,682,730...33,688,332
Ensembl chrNW_004936471:33,682,730...33,688,332
|
|
G |
LOC101976500 |
haptoglobin |
treatment |
ISO |
|
RGD |
PMID:17187421 PMID:21699906 |
RGD:11041815 RGD:1626366 |
NCBI chrNW_004936475:21,841,054...21,845,821
|
|
G |
Map3k7 |
mitogen-activated protein kinase kinase kinase 7 |
ameliorates exacerbates |
ISO |
protein:increased phosphorylation:liver (mouse) |
RGD |
PMID:30076625 PMID:30622220 |
RGD:155804280 RGD:155882441 |
NCBI chrNW_004936510:1,772,971...1,836,075
Ensembl chrNW_004936510:1,772,971...1,837,765
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
protein:increased activity:liver: |
RGD |
PMID:11679968 |
RGD:10412680 |
NCBI chrNW_004936728:1,775,746...1,893,895
Ensembl chrNW_004936728:1,775,641...1,893,907
|
|
G |
Mfn2 |
mitofusin 2 |
treatment |
ISO |
mRNA, protein:decreased expression:liver (rat) |
RGD |
PMID:24898700 PMID:27363631 |
RGD:12910833 RGD:13204829 |
NCBI chrNW_004936474:767,754...795,258
Ensembl chrNW_004936474:767,671...796,556
|
|
G |
Mmp15 |
matrix metallopeptidase 15 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chrNW_004936475:9,951,876...9,971,631
Ensembl chrNW_004936475:9,951,778...9,971,666
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
ISO |
associated with Fatty Liver;mRNA, protein:decreased expression, decreased activity:liver |
RGD |
PMID:17255325 |
RGD:8547976 |
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
mRNA, protein:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chrNW_004936580:4,691,870...4,694,092
|
|
G |
Muc4 |
mucin 4, cell surface associated |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chrNW_004936784:515,608...539,915
|
|
G |
Nfatc1 |
nuclear factor of activated T cells 1 |
|
ISO |
mRNA,protein:increased expression:liver: |
RGD |
PMID:36092961 |
RGD:268357360 |
NCBI chrNW_004936616:484,062...584,950
Ensembl chrNW_004936616:484,045...587,891
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
treatment |
ISO |
|
RGD |
PMID:22288937 PMID:31952110 |
RGD:10403073 RGD:21201304 |
NCBI chrNW_004936509:6,589,967...6,621,171
Ensembl chrNW_004936509:6,590,630...6,620,262
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
|
RGD |
PMID:28966130 |
RGD:13450941 |
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:12605111 PMID:18507760 |
RGD:11100021 RGD:11100046 |
NCBI chrNW_004936469:43,841,989...43,850,322
Ensembl chrNW_004936469:43,841,989...43,850,304
|
|
G |
Rab10 |
RAB10, member RAS oncogene family |
ameliorates |
ISO |
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chrNW_004936493:6,263,870...6,351,327
Ensembl chrNW_004936493:6,263,863...6,351,327
|
|
G |
Rab8b |
RAB8B, member RAS oncogene family |
ameliorates |
ISO |
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chrNW_004936471:23,768,460...23,832,072
Ensembl chrNW_004936471:23,768,415...23,834,129
|
|
G |
Selplg |
selectin P ligand |
ameliorates |
ISO |
|
RGD |
PMID:16365457 |
RGD:401717523 |
NCBI chrNW_004936769:531,224...540,429
|
|
G |
Serpinc1 |
serpin family C member 1 |
treatment |
ISO |
|
RGD |
PMID:8589354 PMID:24726586 |
RGD:10450597 RGD:11038771 |
NCBI chrNW_004936481:13,981,014...13,993,750
Ensembl chrNW_004936481:13,981,019...13,993,634
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
protein:increased activity:plasma (rat) |
RGD |
PMID:12353078 |
RGD:8547901 |
NCBI chrNW_004936543:1,032,543...1,040,956
Ensembl chrNW_004936543:1,032,794...1,039,123
|
|
G |
Serping1 |
serpin family G member 1 |
treatment |
ISO |
|
RGD |
PMID:16367929 |
RGD:1580273 |
NCBI chrNW_004936581:4,911,403...4,924,484
Ensembl chrNW_004936581:4,908,458...4,924,645
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
ISO |
|
RGD |
PMID:24557422 |
RGD:9497542 |
NCBI chrNW_004936521:10,296,097...10,316,673
Ensembl chrNW_004936521:10,296,097...10,322,215
|
|
G |
Sod1 |
superoxide dismutase 1 |
treatment |
ISO |
human gene in a rat model |
RGD |
PMID:11779401 PMID:16555330 |
RGD:1581095 RGD:8655889 |
NCBI chrNW_004936500:10,345,154...10,352,873
Ensembl chrNW_004936500:10,345,154...10,352,867
|
|
G |
Tert |
telomerase reverse transcriptase |
treatment |
ISO |
|
RGD |
PMID:19545665 |
RGD:11038676 |
NCBI chrNW_004936815:468,987...492,666
Ensembl chrNW_004936815:469,020...491,697
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
|
ISO |
|
RGD |
PMID:9921794 |
RGD:11062061 |
NCBI chrNW_004936506:10,103,120...10,172,800
Ensembl chrNW_004936506:10,103,139...10,171,863
|
|
G |
Tlr2 |
toll like receptor 2 |
treatment |
ISO |
|
RGD |
PMID:16038046 PMID:25769561 |
RGD:15090805 RGD:15090809 |
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
|
|
G |
Tlr4 |
toll like receptor 4 |
treatment severity |
ISO |
protein:increased expression:membrane raft: mRNA:increased expression:liver |
RGD |
PMID:21431875 PMID:21693218 PMID:22797797 PMID:23395256 PMID:27064547 |
RGD:10402078 RGD:14697698 RGD:14697699 RGD:14697702 RGD:5685379 |
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
protein:increased expression:serum (rat) |
RGD |
PMID:10454827 PMID:11129814 PMID:11592783 PMID:12131680 PMID:15457564 PMID:17164725 PMID:19357028 PMID:21125813 PMID:24726586 PMID:32155285 More...
|
RGD:10450597 RGD:14696803 RGD:14985257 RGD:14985258 RGD:14995447 RGD:14995454 RGD:14995473 RGD:15039406 RGD:155260323 RGD:2325259 |
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased localization:mitochondrion |
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chrNW_004936709:1,407,327...1,421,448
Ensembl chrNW_004936709:1,407,278...1,421,921
|
|
G |
Tradd |
TNFRSF1A associated via death domain |
treatment |
ISO |
|
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chrNW_004936475:17,628,297...17,634,919
Ensembl chrNW_004936475:17,628,803...17,630,856
|
|
G |
Ucp2 |
uncoupling protein 2 |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:22195248 |
RGD:7175309 |
NCBI chrNW_004936498:3,059,700...3,066,112
Ensembl chrNW_004936498:3,059,297...3,066,197
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
|
RGD |
PMID:26451003 |
RGD:15036791 |
NCBI chrNW_004936476:16,245,134...16,261,180
Ensembl chrNW_004936476:16,247,100...16,260,673
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
ISO |
|
RGD |
PMID:24768926 |
RGD:13209011 |
NCBI chrNW_004936493:1,762,814...1,824,501
Ensembl chrNW_004936493:1,762,869...1,823,238
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment ameliorates |
ISO |
|
RGD |
PMID:23953793 PMID:34238924 |
RGD:10054119 RGD:153350155 |
NCBI chrNW_004936664:2,968,103...2,973,652
Ensembl chrNW_004936664:2,967,865...2,973,820
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chrNW_004936490:11,448,552...11,465,836
Ensembl chrNW_004936490:11,448,654...11,464,444
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chrNW_004936506:8,886,494...8,923,921
Ensembl chrNW_004936506:8,886,494...8,923,930
|
|
G |
Crebbp |
CREB binding protein |
ameliorates |
ISO |
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chrNW_004936694:552,447...663,237
Ensembl chrNW_004936694:553,753...663,617
|
|
G |
Egr1 |
early growth response 1 |
treatment |
ISO |
|
RGD |
PMID:22878149 PMID:23232597 |
RGD:10395282 RGD:10395299 |
NCBI chrNW_004936531:7,625,956...7,629,041
Ensembl chrNW_004936531:7,625,892...7,629,749
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
mRNA:increased expression:lung (rat) |
RGD |
PMID:35600952 |
RGD:155663563 |
NCBI chrNW_004936486:10,506,680...10,606,272
Ensembl chrNW_004936486:10,507,097...10,602,019
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:22115333 |
RGD:10402095 |
NCBI chrNW_004936472:25,236,728...25,246,585
Ensembl chrNW_004936472:25,236,728...25,246,580
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:21227458 |
RGD:10755577 |
NCBI chrNW_004936492:5,042,353...5,049,216
Ensembl chrNW_004936492:5,042,330...5,049,311
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
|
RGD |
PMID:22503847 |
RGD:7240537 |
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
|
|
G |
Il1b |
interleukin 1 beta |
ameliorates |
ISO |
protein:increased expression:lung (rat) |
RGD |
PMID:23122581 PMID:23142117 PMID:34238924 |
RGD:153350155 RGD:7183185 RGD:7204125 |
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G |
Il6 |
interleukin 6 |
ameliorates |
ISO |
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
ameliorates |
ISO |
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chrNW_004936548:2,078,568...2,113,877
Ensembl chrNW_004936548:2,079,036...2,110,523
|
|
G |
LOC101961846 |
neutrophil elastase |
treatment |
ISO |
|
RGD |
PMID:17888675 |
RGD:10450582 |
NCBI chrNW_004936588:345,678...347,420
Ensembl chrNW_004936588:345,678...347,413
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased activity:lung |
RGD |
PMID:18694576 |
RGD:5129703 |
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
treatment |
ISO |
|
RGD |
PMID:22503847 |
RGD:7240537 |
NCBI chrNW_004936470:20,480,844...20,485,955
Ensembl chrNW_004936470:20,480,829...20,485,965
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:20815765 PMID:25382268 |
RGD:11533932 RGD:4892012 |
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:21781312 |
RGD:6771212 |
NCBI chrNW_004936475:19,771,384...19,785,034
Ensembl chrNW_004936475:19,769,488...19,785,311
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
protein:increased expression:alveolar macrophage (rat) |
RGD |
PMID:16449942 PMID:21781312 |
RGD:11541083 RGD:6771212 |
NCBI chrNW_004936541:4,873,459...4,919,787
Ensembl chrNW_004936541:4,873,182...4,937,500
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:19782612 |
RGD:11100035 |
NCBI chrNW_004936469:43,841,989...43,850,322
Ensembl chrNW_004936469:43,841,989...43,850,304
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO |
|
RGD |
PMID:11606484 |
RGD:11080966 |
NCBI chrNW_004936543:1,032,543...1,040,956
Ensembl chrNW_004936543:1,032,794...1,039,123
|
|
G |
Tlr4 |
toll like receptor 4 |
treatment |
ISO |
|
RGD |
PMID:22115333 |
RGD:10402095 |
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
|
|
G |
Tnf |
tumor necrosis factor |
ameliorates |
ISO |
|
RGD |
PMID:17294835 PMID:34238924 |
RGD:153350155 RGD:4143397 |
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
G |
Zfp36 |
ZFP36 ring finger protein |
exacerbates |
ISO |
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chrNW_004936661:2,251,148...2,253,527
Ensembl chrNW_004936661:2,250,665...2,253,787
|
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
|
ISO |
|
RGD |
PMID:18316485 |
RGD:2301903 |
NCBI chrNW_004936528:1,608,782...1,682,873
Ensembl chrNW_004936528:1,608,757...1,682,975
|
|
G |
Acvr2b |
activin A receptor type 2B |
treatment |
ISO |
human construct in mouse model mRNA, protein:decreased expression:heart (mouse) |
RGD |
PMID:30765322 |
RGD:329849112 |
NCBI chrNW_004936473:27,816,366...27,822,555
Ensembl chrNW_004936473:27,815,399...27,822,476
|
|
G |
Ada |
adenosine deaminase |
|
ISO |
protein:increased expression |
RGD |
PMID:16641873 |
RGD:1624305 |
NCBI chrNW_004936530:2,217,713...2,224,070
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16155579 |
|
NCBI chrNW_004936578:3,168,599...3,179,369
Ensembl chrNW_004936578:3,168,331...3,171,928
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10900253 PMID:17201736 |
RGD:5129149 |
NCBI chrNW_004936486:4,400,467...4,401,588
Ensembl chrNW_004936486:4,399,915...4,403,149
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
|
RGD |
PMID:16269402 |
RGD:1598746 |
NCBI chrNW_004936504:5,985,407...5,987,453
Ensembl chrNW_004936504:5,985,960...5,987,210
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
protein:increased expression:heart (rat) |
RGD |
PMID:16505177 |
RGD:1625342 |
NCBI chrNW_004936727:1,418,342...1,422,005
Ensembl chrNW_004936727:1,418,799...1,422,147
|
|
G |
Agl |
amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase |
|
ISO |
|
RGD |
PMID:9281456 |
RGD:1598779 |
NCBI chrNW_004937224:23,225...32,639
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:2535056 PMID:19166939 |
|
NCBI chrNW_004936484:19,713,299...19,721,144
Ensembl chrNW_004936484:19,716,165...19,721,261
|
|
G |
Agtr1 |
angiotensin II receptor type 1 |
|
ISO |
protein:increased expression:myocardium |
RGD |
PMID:21078800 |
RGD:5129194 |
NCBI chrNW_004936519:6,831,096...6,873,977
Ensembl chrNW_004936519:6,831,096...6,873,985
|
|
G |
Ahr |
aryl hydrocarbon receptor |
treatment |
ISO |
|
RGD |
PMID:35788946 |
RGD:401793705 |
NCBI chrNW_004936546:3,737,908...3,783,492
Ensembl chrNW_004936546:3,737,851...3,783,588
|
|
G |
Aifm1 |
apoptosis inducing factor mitochondria associated 1 |
|
ISO |
protein:decreased expression:mitochondrion: |
RGD |
PMID:23685150 |
RGD:10053560 |
NCBI chrNW_004936479:1,441,508...1,477,133
Ensembl chrNW_004936479:1,441,437...1,478,107
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
protein:increased phosphorylation:heart left ventricle |
RGD |
PMID:20217242 |
RGD:5509104 |
NCBI chrNW_004936621:620,163...639,115
Ensembl chrNW_004936621:620,074...639,093
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
|
ISO |
|
RGD |
PMID:16418318 |
RGD:2313347 |
NCBI chrNW_004936661:2,652,568...2,694,039
Ensembl chrNW_004936661:2,652,566...2,694,086
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
|
RGD |
PMID:23468836 |
RGD:7241598 |
NCBI chrNW_004936558:4,362,693...4,387,705
Ensembl chrNW_004936558:4,362,654...4,390,414
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:20011686 |
RGD:2317527 |
NCBI chrNW_004936554:7,807,914...7,848,691
Ensembl chrNW_004936554:7,808,355...7,867,931
|
|
G |
Angpt2 |
angiopoietin 2 |
|
ISO |
mRNA, protein:increased expression:myocardium (rat) |
RGD |
PMID:12737621 |
RGD:1601505 |
NCBI chrNW_004936615:4,472,261...4,524,537
Ensembl chrNW_004936615:4,472,247...4,524,556
|
|
G |
Ank1 |
ankyrin 1 |
|
ISO |
|
RGD |
PMID:9378703 |
RGD:1599110 |
NCBI chrNW_004936785:738,323...944,734
Ensembl chrNW_004936785:738,317...942,381
|
|
G |
Ank2 |
ankyrin 2 |
|
ISO |
|
RGD |
PMID:9378703 |
RGD:1599110 |
NCBI chrNW_004936563:3,520,195...4,170,716
Ensembl chrNW_004936563:3,520,193...4,171,362
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
|
ISO |
protein:decreased expression:myocardium |
RGD |
PMID:19299913 |
RGD:5133278 |
NCBI chrNW_004936601:3,502,844...3,510,919
Ensembl chrNW_004936601:3,502,844...3,511,003
|
|
G |
Anxa1 |
annexin A1 |
treatment |
ISO |
protein:increased expression:heart, leukocyte |
RGD |
PMID:11641252 PMID:22924634 |
RGD:2306910 RGD:7421655 |
NCBI chrNW_004936503:9,124,314...9,142,372
Ensembl chrNW_004936503:9,124,264...9,142,413
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
ISO |
protein:altered localization:cytoplasm |
RGD |
PMID:17602955 |
RGD:2315672 |
NCBI chrNW_004936877:666,545...669,351
Ensembl chrNW_004936877:666,523...669,338
|
|
G |
Arrb2 |
arrestin beta 2 |
|
ISO |
|
RGD |
PMID:29016703 |
RGD:13506827 |
NCBI chrNW_004936677:3,173,054...3,181,475
Ensembl chrNW_004936677:3,172,925...3,181,520
|
|
G |
Atf3 |
activating transcription factor 3 |
|
ISO |
|
RGD |
PMID:11485922 |
RGD:7327201 |
NCBI chrNW_004936557:909,302...922,619
Ensembl chrNW_004936557:908,318...922,624
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29702141 |
|
NCBI chrNW_004936627:1,555,151...1,584,370
Ensembl chrNW_004936627:1,554,873...1,584,638
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
|
ISO |
|
RGD |
PMID:17630344 |
RGD:13782075 |
NCBI chrNW_004936501:11,818,301...11,836,221
Ensembl chrNW_004936501:11,816,585...11,836,231
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10734148 PMID:28637456 |
RGD:13782080 |
NCBI chrNW_004936558:3,300,941...3,357,595
Ensembl chrNW_004936558:3,300,941...3,357,941
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
treatment |
ISO |
protein:decreased expression:myocardium (rat) |
RGD |
PMID:25305180 PMID:26109848 |
RGD:13792666 RGD:13792676 |
NCBI chrNW_004936588:612,255...614,894
Ensembl chrNW_004936588:611,725...617,782
|
|
G |
Bad |
BCL2 associated agonist of cell death |
treatment |
ISO |
protein:increased expression, decreased serine phosphorylation:heart |
RGD |
PMID:15339931 PMID:23364609 |
RGD:10053674 RGD:2292700 |
NCBI chrNW_004936599:4,924,349...4,933,683
Ensembl chrNW_004936599:4,924,789...4,933,368
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20026869 PMID:21223820 PMID:25547710 PMID:31583047 |
RGD:10054103 RGD:13782178 RGD:155230831 |
NCBI chrNW_004936664:2,968,103...2,973,652
Ensembl chrNW_004936664:2,967,865...2,973,820
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:16289365 PMID:20821058 PMID:23364609 PMID:31583047 |
RGD:10053674 RGD:11561911 RGD:155230831 RGD:1599484 |
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G |
Bcl2l1 |
BCL2 like 1 |
treatment |
ISO |
|
RGD |
PMID:12668130 |
RGD:11035287 |
NCBI chrNW_004936485:18,654,046...18,707,324
|
|
G |
Becn1 |
beclin 1 |
treatment |
ISO |
|
RGD |
PMID:20812860 PMID:20821058 |
RGD:11561911 RGD:11561944 |
NCBI chrNW_004936490:17,518,100...17,531,126
Ensembl chrNW_004936490:17,517,751...17,531,151
|
|
G |
Bid |
BH3 interacting domain death agonist |
|
ISO |
protein:increased cleavage:heart: |
RGD |
PMID:11934844 PMID:19940077 |
RGD:13782263 RGD:2317561 |
NCBI chrNW_004936807:708,340...750,127
Ensembl chrNW_004936807:708,276...750,093
|
|
G |
Blk |
BLK proto-oncogene, Src family tyrosine kinase |
|
ISO |
mRNA:increased expression:left ventricle (rat) |
RGD |
PMID:17562528 |
RGD:1642307 |
NCBI chrNW_004936675:3,228,982...3,246,617
Ensembl chrNW_004936675:3,229,154...3,246,292
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
treatment |
ISO |
protein:decreased expression:myocardium (human) |
RGD |
PMID:16645637 PMID:28661226 |
RGD:11561983 RGD:155260328 |
NCBI chrNW_004936486:18,449,371...18,460,435
Ensembl chrNW_004936486:18,448,494...18,455,927
|
|
G |
Brd4 |
bromodomain containing 4 |
|
ISO |
mRNA,protein:increased expression:heart |
RGD |
PMID:33982231 |
RGD:155883171 |
NCBI chrNW_004936596:5,176,682...5,246,102
Ensembl chrNW_004936596:5,177,147...5,246,518
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
|
ISO |
mRNA:increased expression:heart |
RGD |
PMID:12909328 |
RGD:2289075 |
NCBI chrNW_004936567:1,310,525...1,314,469
Ensembl chrNW_004936567:1,309,658...1,314,515
|
|
G |
C3 |
complement C3 |
|
ISO |
protein:increased expression:myocardium |
RGD |
PMID:11560858 |
RGD:1582136 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
C5 |
complement C5 |
treatment |
ISO |
|
RGD |
PMID:9631876 PMID:23067403 |
RGD:1600666 RGD:7411626 |
NCBI chrNW_004936487:9,391,774...9,474,168
Ensembl chrNW_004936487:9,391,804...9,474,159
|
|
G |
Casp3 |
caspase 3 |
treatment ameliorates |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:14998631 PMID:18470603 PMID:29538428 PMID:30259997 |
RGD:13782276 RGD:2293314 RGD:329337366 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Casp7 |
caspase 7 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:14998631 PMID:29538428 |
RGD:13782276 |
NCBI chrNW_004936486:4,082,664...4,114,942
Ensembl chrNW_004936486:4,088,372...4,114,955
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte |
CTD RGD |
PMID:11934844 PMID:14998631 |
RGD:13782263 |
NCBI chrNW_004936726:554,627...596,334
Ensembl chrNW_004936726:554,758...595,922
|
|
G |
Casp9 |
caspase 9 |
treatment ameliorates |
ISO |
protein:increased activity:cardiomyocyte,endothelial cell CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11934844 PMID:14998631 PMID:29538428 PMID:30259997 |
RGD:13782263 RGD:13782276 RGD:329337366 |
NCBI chrNW_004936474:3,178,097...3,196,130
|
|
G |
Casr |
calcium sensing receptor |
|
ISO |
protein:increased expression:ventricular myocardium (rat) |
RGD |
PMID:21766206 |
RGD:7205698 |
NCBI chrNW_004936536:8,574,064...8,599,446
Ensembl chrNW_004936536:8,574,064...8,599,454
|
|
G |
Cast |
calpastatin |
ameliorates |
ISO |
human transcript overexpression in rat model |
RGD |
PMID:12482022 PMID:14519437 |
RGD:405101692 RGD:5683872 |
NCBI chrNW_004936523:6,688,153...6,798,184
Ensembl chrNW_004936523:6,686,519...6,798,321
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:11510883 PMID:21600015 |
RGD:1581149 |
NCBI chrNW_004936533:3,601,270...3,637,128
Ensembl chrNW_004936533:3,600,955...3,637,422
|
|
G |
Cbl |
Cbl proto-oncogene |
severity |
ISO |
|
RGD |
PMID:24583314 |
RGD:11251947 |
NCBI chrNW_004936542:4,136,389...4,235,746
Ensembl chrNW_004936542:4,136,511...4,228,288
|
|
G |
Cflar |
CASP8 and FADD like apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:18466417 |
RGD:11341714 |
NCBI chrNW_004936726:381,888...425,565
Ensembl chrNW_004936726:381,835...423,311
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
|
RGD |
PMID:18771032 |
RGD:2316217 |
NCBI chrNW_004936510:3,779,930...3,806,615
Ensembl chrNW_004936510:3,781,210...3,802,693
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
|
ISO |
|
RGD |
PMID:17950273 |
RGD:2316224 |
NCBI chrNW_004936474:9,019,044...9,020,110
Ensembl chrNW_004936474:9,019,067...9,020,110
|
|
G |
Cobll1 |
cordon-bleu WH2 repeat protein like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34355838 |
|
NCBI chrNW_004936469:14,424,538...14,575,228
Ensembl chrNW_004936469:14,424,145...14,575,121
|
|
G |
Crebbp |
CREB binding protein |
treatment |
ISO |
|
RGD |
PMID:24338162 |
RGD:153352322 |
NCBI chrNW_004936694:552,447...663,237
Ensembl chrNW_004936694:553,753...663,617
|
|
G |
Crp |
C-reactive protein |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21122204 |
RGD:5128547 |
NCBI chrNW_004936740:885,855...888,854
Ensembl chrNW_004936740:883,272...890,606
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
protein:decreased expression:blood, monocyte |
RGD |
PMID:15786508 |
RGD:4892017 |
NCBI chrNW_004936473:28,508,726...28,535,640
Ensembl chrNW_004936473:28,510,523...28,535,627
|
|
G |
Diablo |
diablo IAP-binding mitochondrial protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14998631 |
|
NCBI chrNW_004936558:2,260,459...2,268,941
Ensembl chrNW_004936558:2,260,359...2,268,941
|
|
G |
Dnm1l |
dynamin 1 like |
ameliorates |
ISO |
|
RGD |
PMID:30259997 |
RGD:329337366 |
NCBI chrNW_004936607:3,576,357...3,632,423
Ensembl chrNW_004936607:3,576,392...3,632,554
|
|
G |
Ece1 |
endothelin converting enzyme 1 |
|
ISO |
|
RGD |
PMID:12193087 PMID:18586023 |
RGD:4892580 RGD:7244160 |
NCBI chrNW_004936474:7,034,134...7,083,005
Ensembl chrNW_004936474:7,034,134...7,083,005
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15642760 PMID:16700825 PMID:18586023 |
RGD:4892580 |
NCBI chrNW_004936534:885,489...892,292
Ensembl chrNW_004936534:885,287...891,772
|
|
G |
Ednra |
endothelin receptor type A |
|
ISO |
|
RGD |
PMID:18586023 |
RGD:4892580 |
NCBI chrNW_004936535:1,950,117...2,005,786
Ensembl chrNW_004936535:1,949,941...2,005,910
|
|
G |
Ednrb |
endothelin receptor type B |
|
ISO |
|
RGD |
PMID:21048781 |
RGD:4892332 |
NCBI chrNW_004936511:3,446,864...3,478,434
Ensembl chrNW_004936511:3,446,839...3,478,434
|
|
G |
Egln1 |
egl-9 family hypoxia inducible factor 1 |
susceptibility |
ISO |
|
RGD |
PMID:20185832 |
RGD:11251775 |
NCBI chrNW_004936484:19,343,770...19,386,087
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19834332 |
|
NCBI chrNW_004936675:350,357...392,919
Ensembl chrNW_004936675:350,342...392,551
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
|
RGD |
PMID:18314151 |
RGD:4892299 |
NCBI chrNW_004936489:4,616,839...4,887,179
Ensembl chrNW_004936489:4,614,754...4,887,171
|
|
G |
Esr2 |
estrogen receptor 2 |
|
ISO |
|
RGD |
PMID:18656630 |
RGD:5508820 |
NCBI chrNW_004936495:7,956,168...8,018,356
Ensembl chrNW_004936495:7,956,766...8,004,357
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
ISO |
|
RGD |
PMID:26038570 PMID:26948086 |
RGD:11341801 RGD:13792504 |
NCBI chrNW_004936599:633,501...639,412
Ensembl chrNW_004936599:633,330...639,456
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
|
RGD |
PMID:21316771 |
RGD:8686424 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Fis1 |
fission, mitochondrial 1 |
ameliorates |
ISO |
|
RGD |
PMID:30259997 |
RGD:329337366 |
NCBI chrNW_004936543:1,112,746...1,116,521
Ensembl chrNW_004936543:1,112,742...1,116,518
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
treatment |
ISO |
|
RGD |
PMID:27129213 |
RGD:11574725 |
NCBI chrNW_004936709:1,243,149...1,247,782
Ensembl chrNW_004936709:1,243,147...1,247,903
|
|
G |
Gcg |
glucagon |
treatment |
ISO |
|
RGD |
PMID:24125539 |
RGD:10402369 |
NCBI chrNW_004936469:16,906,658...16,916,045
Ensembl chrNW_004936469:16,906,658...16,916,045
|
|
G |
Gdf11 |
growth differentiation factor 11 |
|
ISO |
mRNA, protein:decreased expression:heart (mouse) |
RGD |
PMID:30765322 |
RGD:329849112 |
NCBI chrNW_004936646:215,101...227,296
Ensembl chrNW_004936646:216,946...224,321
|
|
G |
Gja1 |
gap junction protein alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17445419 |
|
NCBI chrNW_004936658:3,920,043...3,932,987
Ensembl chrNW_004936658:3,920,043...3,932,987
|
|
G |
Glrx |
glutaredoxin |
|
ISO |
mRNA:decreased expression:heart: |
RGD |
PMID:18163565 |
RGD:2306160 |
NCBI chrNW_004936523:7,535,650...7,544,339
Ensembl chrNW_004936523:7,535,857...7,541,864
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
ISO |
|
RGD |
PMID:11043918 |
RGD:401827843 |
NCBI chrNW_004936647:3,904,787...3,914,223
Ensembl chrNW_004936647:3,906,113...3,913,498
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
severity susceptibility treatment |
ISO |
associated with Hypertension protein:increased expression:heart, mitochondrion (mouse) associated with Diabetes Mellitus, Experimental |
RGD |
PMID:23467820 PMID:24170934 PMID:27296507 PMID:27601479 PMID:27865836 |
RGD:13513990 RGD:13513993 RGD:13513995 RGD:13792704 RGD:13792779 |
NCBI chrNW_004936599:2,437,061...2,456,141
Ensembl chrNW_004936599:2,437,032...2,456,147
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
treatment |
ISO |
|
RGD |
PMID:20217242 PMID:26918336 PMID:29978610 |
RGD:13792725 RGD:13792772 RGD:5509104 |
NCBI chrNW_004936536:6,730,070...6,893,818
Ensembl chrNW_004936536:6,730,062...6,894,303
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
ISO |
|
RGD |
PMID:24769323 |
RGD:10401892 |
NCBI chrNW_004936792:531,076...579,083
Ensembl chrNW_004936792:531,756...579,166
|
|
G |
Hdac3 |
histone deacetylase 3 |
ameliorates |
ISO |
|
RGD |
PMID:33982231 |
RGD:155883171 |
NCBI chrNW_004936504:12,530,546...12,546,556
Ensembl chrNW_004936504:12,530,528...12,546,556
|
| |